Právní předpis byl sestaven k datu 27.01.2025.
Zobrazené znění právního předpisu je účinné od 22.08.2023 do 27.01.2025.
32
SDĚLENÍ
Ministerstva xxxxxxxxxxxx věcí, xxxxxx xx mění x doplňují xxxxxxx Xxxxxxxxxxxx zahraničních xxxx x. 58/2007 Xx. x. x. a x. 46/2008 Xx. x. x.
&xxxx;
Xxxxxxxxxxxx zahraničních xxxx xxxxxxx, xx xxx 15. listopadu 2022 bylo xxxxxxxxx xxxxxxxxxx XXXXXX xxxxxxxx xxxxxxxxx xxxxxx xxxxx Xxxxxxx X (Seznam xxxxxxxxxx xxxxx a xxxxx xxxxxxx pro xxx 2023 - Xxxxxxxxxxx standard) x Xxxxxxx XX - Xxxxxxxxxxx standard xxx xxxxxxxxxxxx výjimky xxx xxx 2023 Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx1).
X novým xxxxxx Xxxxxxx X x Přílohy II xxxxxxxx xxxxxxx Parlament Xxxxx xxxxxxxxx a xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx x xxxxxxx xxxx Xxxxxxx I x Xxxxxxx XX Xxxxxx xxxxxxxxxx.
Xxxx znění Xxxxxxx X x Xxxxxxx II xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx xxx 1. ledna 2023, pro Xxxxxx xxxxxxxxx xxxxxxxxx v xxxxxxxx dne 22. xxxxxx 2023 x xxxxxxxxx
- Přílohu I xxx xxx 20222), xxxxx xxxxxxxxx x xxxxxxxx xxx 1. xxxxx 2022 a xxx Xxxxxx xxxxxxxxx xxxxxxxxx v xxxxxxxx xxx 27. dubna 2023, xxxxx xxxxxxxxx Xxxxxxx X pro xxx 20183), platnou xx 1. ledna 2018, xxxxx xxxxxxxxx x xxxxxxxx xxx Xxxxxx republiku xxx 5. xxxxxx 2019,
x
- Xxxxxxx XX xxx xxx 20164), která xxxxxxxxx v xxxxxxxx xxx 14. xxxxxx 2016 a xxx Xxxxxx republiku xxxxxxxxx x xxxxxxxx dne 24. xxxxx 2017.
Xxxxxxxx xxxxx Přílohy I x Xxxxxxx II xxx rok 2023 x xxxxxx xxxxxxx xx českého xxxxxx xx xxxxxxxxx xxxxxxxx.
XXXXXXX
XXXXXXX XXXXXXXXXXXXX XXXXX
XXXXXXXXXXX XXXXXXXX
XXXXXX XXXXXXXXXX
XXXXX X METOD
2023
Tento Xxxxxx xx xxxxxx xx 1.1.2023.
OBSAH
Níže xxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxx xxxxxxxxxxx stavů xxxxxx xxx úplný.
|
LÁTKY A XXXXXX XXXXXXXX XXXXXX |
|
|
X0 Xxxxxxxxxxx xxxxx |
|
|
X1 Anabolické xxxxx |
|
|
Xxxxxxx x xxxxxx xxxxx xxx bez xxxxxxx nalézt v xxxxxx používaných x xxxxx xxxx. mužského xxxxxxxxxxxxx. |
|
|
X2 Xxxxxxxxx hormony, xxxxxxx xxxxxxx, příbuzné xxxxx x xxxxxxxx |
|
|
Xxxxxxx x těchto xxxxx xxx bez xxxxxxx xxxxxx x lécích xxxxxxxxxxx x xxxxx xxxx. xxxxxx, mužského xxxxxxxxxxxxx x xxxxxxxxxx xxxxxxxxx hormonu. |
|
|
S3 Xxxx-2 xxxxxxxx |
|
|
Xxxxxxx x těchto xxxxx xxx xxx xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx k xxxxx např. xxxxxxx x xxxxxx xxxxxxxxxxxx xxxxxx. |
|
|
X4 Xxxxxxxxx a xxxxxxxxxxx xxxxxxxxxx |
|
|
Xxxxxxx x xxxxxx xxxxx xxx xxx xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx x léčbě např. xxxxxxxx xxxx, cukrovky, xxxxxx neplodnosti, xxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx. |
|
|
X5 Xxxxxxxxx x xxxxxxxxx xxxxx. |
|
|
Xxxxxxx x těchto xxxxx xxx xxx xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx x xxxxx xxxx. srdečního xxxxxxx, xxxxxxxxxx. |
|
|
X1–X2–X3 Xxxxxxxx xxxxxx |
|
|
XXXXX X XXXXXX XXXXXXXX XXX XXXXXXX |
|
|
X6 Stimulancia |
|
|
Některé x xxxxxx xxxxx xxx xxx xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx x xxxxx xxxx. anafylaxe, poruchy xxxxxxxxxx spolu s xxxxxxxxxxxxxx (XXXX), příznaků xxxxxxxxxx x xxxxxxx. |
|
|
X7 Xxxxxxxxx |
|
|
Xxxxxxx z xxxxxx xxxxx xxx bez xxxxxxx xxxxxx x xxxxxx používaných x xxxxx xxxx. bolesti xxxxxx poranění xxxxxxxxxx xxxxxxx. |
|
|
X8 Kanabinoidy |
|
|
S9 Glukokortikoidy |
|
|
Některé x xxxxxx látek xxx bez xxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx x léčbě xxxx. alergie, xxxxxxxxx, xxxxxxx, zánětlivých xxxxxxxxxxxx xxxxx. |
|
|
XXXXX ZAKÁZANÉ X XXXXXXXXX SPORTECH |
|
|
P1 Xxxx-xxxxxxxxx |
|
|
Xxxxxxx x xxxxxx xxxxx xxx xxx xxxxxxx xxxxxx v xxxxxx xxxxxxxxxxx x léčbě xxxx. xxxxxxxxx xxxxxxx, xxxxxxxxxx. |
|
|
XXXXXXXX |
|
XXXXXX ZAKÁZANÝCH XXXXX X METOD XXXXXXX 2023
XXXXXXX ANTIDOPINGOVÝ KODEX
ÚČINNÝ XX 1. XXXXX 2023
Xxxx
Xxxxxx&xxxx;xxxxxxxxxx látek x xxxxx dopingu (Seznam) xx xxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxx&xxxx;xxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx.
Xxxxxx&xxxx;xx aktualizuje xxxxxx xxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxxxx&xxxx;XXXX. Xxxxx xxxxxxxxx&xxxx;Xxxxxxx&xxxx;xx 1. xxxxx 2023.
Xxxxxxxxx znění Seznamu zakázaných xxxxx a xxxxx xxxxxxx xx xxx xxxxxxx&xxxx;XXXX&xxxx;x je xxxxxxxxxxx x xxxxxxxxx x xxxxxxxxxxxx jazyce. X xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx xxxxxxxxx a xxxxxxxxxxxx xxxxx xx xxxxxxxx ta anglická.
Níže xxxx uvedené xxxxxxx xxxxxxxx xxxxxxxxx x&xxxx;Xxxxxxx xxxxxxxxxx látek a xxxxx.
Xxxxxxxx Xxx Xxxxxxx
X xxxxxxxx xxxxxx období, xxxxx by WADA schválila xxx xxxxxx sport, xx xxxxxx&xxxx;Xxx Xxxxxxx&xxxx;x xxxxxx xxxxxx xxxxxxxxxx xxxxx xxxx xxxxxxx (xx 23:59) xxx xxxx&xxxx;Xxxxxxx, xxxxx se má Sportovec účastnit, xx xx xxxxx&xxxx;Xxxxxxx&xxxx;x xxxxxxx xxxxxx&xxxx;Xxxxxx.
Xxxxxxxx xxxxx
Xxxxx xxxx xxxxxx xx xxxxxxxx xxx&xxxx;Xxx Soutěži, xxx x&xxxx;Xxxx Xxxxxx, xxx xx definováno x&xxxx;Xxxxxx.
Xxxxxxxxxx x nespecifické
Podle xxxxxx 4.2.2&xxxx;Xxxxxxxxx antidopingového Xxxxxx&xxxx;"Xxx xxxxx xxxxxxxx xxxxxx 10 xxxxx xxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;Xxxxxxxxxxxx xxxxxxx, xxxxx xxxxx xxxxxxxxxx x&xxxx;Xxxxxxx. Xxxxx&xxxx;Xxxxxxxx metoda nebude Specifickou xxxxxxx, pokud xxxx x&xxxx;Xxxxxxx&xxxx;xxxxxxxxx xxxxxxxx jako Specifická xxxxxx.". Xxxxx xxxxxxxxx x xxxxxx 4.2.2 xxxxx "Xxxxxxxxxx xxxxx&xxxx;x&xxxx;xxxxxx&xxxx;xxxxxxx x xxxxxx 4.2.2 xxxxx xxxxxxx xxxxxxxxx xx xxxx důležité xxxx xxxx nebezpečné xxx jiné xxxxxxxxx xxxxx xx xxxxxx. Xxxxxxxxx xxx spíše x xxxxx, xxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxx xxxxxxxxxxxxxxxx použije xx xxxxx účelem xxx xxx xxxxxxx xxx xxxxxxxxx xxxxxxxxxx."
Xxxxxxxx xxxxx
Xxxxx xxxxxx 4.2.3&xxxx;Xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxxxxxxxx xxxx "Xxxxxxxx xxxxx, xxxxx xxxx x&xxxx;Xxxxxxx&xxxx;xxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxx xxxxx&xxxx;x důvodu xxxxxx xxxxxxx xxxxxxxxxx ve xxxxxxxxxxx xxxx xxxxx xxxxxx". Xxxxxxxxxxx xxxxx xxxx xxxxxxxxxx jako Návykové xxxxx: xxxxxx, xxxxxxxxx (xxxxxx), xxxxxxxxxxxxxxxxxxxxxxxx (MDMA/"extáze") x xxxxxxxxxxxxxxxxxxx (XXX).
X0 XXXXXXXXXXX XXXXX
XXXXXXXX XXXXX (XXX SOUTĚŽI X XXXX SOUTĚŽ)
Všechny xxxxxxxx xxxxx xxxx považovány xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxxxx farmaceutická xxxxx, xxxxx xxxx xxxxxxxx v xxxxxxxxxxxxx xxxxxxxxxxx&xxxx;Xxxxxxx&xxxx;x xxxx aktuálně xxxxxxxxx xxx xxxxxxx xxxxxxxxxxxx použití jakýmkoliv xxxxxxx zdravotnickým xxxxxxxxxx xxxxxx (xxxx. xxxxxx x preklinickém nebo xxxxxxxxx xxxxxx xxxxxxx xxxx xx xxxxxxxxx xxxxxxx, syntetické drogy, xxxxx xxxxxxxxx pouze xxx veterinární xxxxxxx), xx xxxxxxxx xxxxx.
Xxxx xxxxxxxxx xxxxxxxx xxxxx xxxxxxx látek xxxxxx, xxx bez xxxxxxx xx XXX-157.
X1 XXXXXXXXXX XXXXX
XXXXXXXX XXXXX (XXX XXXXXXX I XXXX XXXXXX)
Xxxxxxx xxxxxxxx xxxxx x xxxx xxxxxxxxx xxxx považovány xx Xxxxxxxxxxxx xxxxx.
Xxxxxxxxxx xxxxx xxxx xxxxxxxx.
1.&xxxx;XXXXXXXXXX XXXXXXXXXX XXXXXXXX (XXX)
Xxx exogenním xxxxxx včetně, xxx xx x omezením xxxxx na xx:
•&xxxx;1-xxxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx)
•&xxxx;1-xxxxxxxxxxxxxx (5α-androst-1-en-3,17-dion)
• 1-androsteron (3α-xxxxxxx-5α-xxxxxxx-1-xx-17-xx)
•&xxxx;1-xxxxxxxxxxxxxx (3ß-xxxxxxx-5α-xxxxxxx-1-xx-17-xx)
•&xxxx;1-xxxxxxxxxxx (17ß-hydroxy-5α-androst-1-en-3-on)
• 4-androstenediol (androst-4-en-3ß,17ß-diol)
• 4-hydroxytestosteron (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx)
•&xxxx;5-xxxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)
•&xxxx;7α-xxxxxxx-XXXX
•&xxxx;7ß-xxxxxxx-XXXX
•&xxxx;7-xxxx-XXXX
•&xxxx;17α-xxxxxxxxxxxxxxxxxxx (xxxxxxxx)
•&xxxx;19-xxxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx)
•&xxxx;19-xxxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx)
•&xxxx;Xxxxxxx-4-xxx-3,11,17-xxxxxx (11-xxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxxx (5α-xxxxxxxxxxxxxxxxxx, 17ß-xxxxxxx-5α-xxxxxxxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxx (xxxxxxx-5-xx-3ß,17ß-xxxx)
•&xxxx;xxxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx)
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx)
•&xxxx;xxxxxxx ([1,2]xxxxxxx[4’,5’:2,3]xxxxxx-4-xx-20-xx-17α-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxxxxx (17α-xxxxx-5α-xxxxxxx-2-xx-17ß-xx x 17α-xxxxx-5α-xxxxxxx-3-xx-17ß-αx)
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx (3ß-hydroxy-5α-androstan-17-on)
• epi-dihydrotestosteron (17ß-xxxxxxx-5ß-xxxxxxxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx (19-norpregna-4-en-17α-ol)
• fluoxymesteron
• formebolon
• furazabol (17α-xxxxx [1,2,5] xxxxxxxxxx[3’,4,:2,3]-5α-xxxxxxxxx-173-xx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx (17ß-xxxxxxx-2α,17α-xxxxxxx-5α-xxxxxxxxx-3-xx)
•&xxxx;xxxxx-1-xxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxx-4-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx (metyltrienolon) (17ß-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx (19-xxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxx (4-xxxxxx-17ß-xx-xxxx-4-xx-3-xx)
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx)
•&xxxx;xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18x-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx)
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx (17ß-hydroxyestr-4,9,11-trien-3-on)
a xxxxx xxxxx x xxxxxxxx xxxxxxxxx strukturou xxxx xxxxxxxxx xxxxxxxxxxxx účinky.
2. OSTATNÍ XXXXXXXXXX LÁTKY
Včetně, xxx xx x xxxxxxxx xxxxx xx ně:
Clenbuterol, xxxxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx receptorů (XXXX, xxxx. xxxxxxx, xxxxxxxxx (xxxxxxx), XXX-4033 (xxxxxxxxx), RAD140, X-23 x XX-11), xxxxxxx x xxxxxxxxxx.
X2 PEPTIDOVÉ XXXXXXX RŮSTOVÉ XXXXXXX, XXXXXXXX XXXXX X XXXXXXXX
XXXXXXXX XXXXX (PŘI XXXXXXX I XXXX XXXXXX)
Xxxxxxx xxxxxxxx látky x xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxx.
Xxxxxxxxxxx xxxxx x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx jsou zakázány.
1. ERYTROPOETINY (XXX) X XXXXXXXXXX XXXXXXXXXXX XXXXXXXXXXX
Xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
1.1&xxxx;Xxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxxx, xxxx. xxxxxxxxxxxx (dEPO); xxxxxxxxxxxxx (XXX); xxxxxxxxxx xxxxxxxx xx XXX, např. XXX-Xx, metoxypolyetylenglykol-epoetin xxxx (XXXX); XXX-xxxxxxxxx xxxxxxxxxx x jejich xxxxxxxxxx, xxxx. CNTO-530, xxxxxxxxxxx.
1.2&xxxx;Xxxxxxxxx xxxxxxxxxx xxxxxxx vyvolávajícího xxxxxxx (XXX), xxxx. xxxxxx; xxxxxxxxxxx (GSK1278863); XXX2 xxxxxxxxxx (XXX 85-3934); roxadustat (XX-4592); xxxxxxxxxx (XXX-6548); xxxxx.
1.3&xxxx;Xxxxxxxxxx XXXX, např. X-11706.
1.4&xxxx;Xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxx xxxx (XXX-ß), xxxx. xxxxxxxxxxxx; xxxxxxxxxxx.
1.5&xxxx;Xxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxx, xxxx. asialo XXX; xxxxxxxxxxxxx EPO (CEPO).
2. PEPTIDOVÉ XXXXXXX A XXXXXX XXXXXXXXXX XXXXXXX
2.1&xxxx;Xxxxxxxxxxxxxxxxxx (XX) x xxxxxxxxxxxx hormon (XX) x xxxxxx xxxxxxxxxx xxxxxxx u xxxx, např. xxxxxxxxx, xxxxxxxxxx, gonadorelin, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx a xxxxxxxxxxx.
2.2&xxxx;Xxxxxxxxxxxxxx a xxxxxx xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxxxxx.
2.3&xxxx;Xxxxxxx hormon (XX), xxxx analogy a xxxxxxxxx, xxxxxx, xxx xx x omezením xxxxx xx xx:
•&xxxx;xxxxxxx xxxxxxxxx hormonu, xxxx. xxxxxxxxxxxxxxxxx, somapacitan x xxxxxxxxxx;
•&xxxx;xxxxxxxxx xxxxxxxxx xxxxxxx, xxxx. XXX-9604 x xXX 176-191.
2.4&xxxx;Xxxxxxx xxxxxxxxxx xxxxxxx xxxxxx, xxxxxx, xxx xx s xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxx xxxxxxxxxx růstový xxxxxx (XXXX) x xxxx analoga, xxxx. XXX-1293, XXX-1295, xxxxxxxxxx xxx xxxxxxxxxxx);
•&xxxx;xxxxxxxxxxx xxxxxxxxx xxxxxxx (GHS) a xxxxxx xxxxxxxx, xxxx. xxxxxxxxxxx (xxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxx x xxxxxxxxxxx;
•&xxxx;xxxxxxxxxx peptidy xxxxxxxxx xxxxxxx GH (XXXX), xxxx. xxxxxxxxxxxx, GHRP-1, XXXX-2 (xxxxxxxxxxx), GHRP-3, XXXX-4, XXXX-5, XXXX-6, x xxxxxxxxxx (xxxxxxxxx).
3.&xxxx;XXXXXXX XXXXXXX A MODULÁTORY XXXXXXXXX XXXXXXX
Xxxxxx, xxx xx s xxxxxxxx xxxxx na xx:
•&xxxx;xxxxxxxxxxxxx xxxxxxx xxxxxxx (XXX);
•&xxxx;xxxxxxxxxxxx xxxxxxx faktor (HGF);
• insulinu xxxxxxx xxxxxxx xxxxxx 1 (XXX-1) x xxxx xxxxxxx;
•&xxxx;xxxxxxxxxx růstové xxxxxxx (XXX);
•&xxxx;xxxxxxx faktory xxxxxxxx x krevních xxxxxxxx (PDGF);
• thymosin-ß4 x xxxx xxxxxxxx, xxxx. XX-500;
•&xxxx;xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx faktor (XXXX);
x další xxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxx nebo degradaci xxxxxxxx xxxxx, xxxxx xxxx vaziva, xxxxxxxxxxxxx, xxxxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxx svalových vláken.
S3 XXXX-2 XXXXXXXX
XXXXXXXX XXXXX (XXX XXXXXXX X XXXX SOUTĚŽ)
Všechny zakázané xxxxx v této xxxxxxxxx xxxx považovaný xx&xxxx;Xxxxxxxxxx látky.
Všichni xxxxxxxxxx x xxxxxxxxxxxx beta-2 xxxxxxxx xxxxxx xxxxx xxxxxxxxx xxxxxxx xxxx xxxxxxxx.
Xxxxxx, xxx xx x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx (trimetoquinol)
• tulobuterol
• vilanterol
VÝJIMKY
• Inhalační xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx v xxxxxxxxxx xxxxxxx, xxxxxxxxxxxxxxxx 600 xxxxxxxxxx xxxxx 8 xxxxx xx jakékoliv xxxxx;
•&xxxx;xxxxxxxxx xxxxxxxxxx: maximálně xxxxxx dávka 54 xxxxxxxxxx xx 24 xxxxx;
•&xxxx;xxxxxxxxx salmeterol: xxxxxxxxx 200 xxxxxxxxxx xx 24 hodin;
• inhalační vilanterol: xxxxxxxxx 25 mikrogramů xx 24 xxxxx.
! XXXXXXXX
Xxxxxxxxxx salbutamolu x xxxx x xxxxxxxxxxx xxxxx než 1000 xx/xx x xxxxxxxxxx xxxxxxxxxxx x moči x xxxxxxxxxxx vyšší xxx 40 ng/ml xxxxxx xxxxxxxxxx za xxxxxxxxxxxx použití, xxx xxxx xxxxxxxxxx za Pozitivní xxxxxxxxxxx xxxxx (XXX), xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxx, že xxxxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxx dávkou (x xxxxxxxx) xxxxx než xxxx xxxxxxx maximální xxxxx.
X4 XXXXXXXXX X XXXXXXXXXXX XXXXXXXXXX
XXXXXXXX XXXXX (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxxx látky v xxxxxxxxxxx S4.1. x X4.2. jsou xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx. Xxxxx x kategoriích X4.3. x S4.4. xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxx.
Xxxxxxxxxxx xxxxxxxxx x metabolické xxxxxxxxxx jsou xxxxxxxx.
4.1.&xxxx;XXXXXXXXXX XXXXXXXX
Xxxxxx, xxx ne x xxxxxxxx xxxxx xx xx:
•&xxxx;2-xxxxxxxxxxx (5α-xxxxxxx-2-xx-17-xx)
•&xxxx;2-xxxxxxxxxxx (5α-xxxxxxx-2-xx-17-xx)
•&xxxx;3-xxxxxxxxxxx (5α-xxxxxxx-3-xx-17-xx)
•&xxxx;3-xxxxxxxxxxx (5α-androst-3-en-17-on)
• 4-androsten-3,6,17 xxxxx (6-oxo)
• aminoglutetimid
• anastrozol
• androsta-1,4,6-trien-3,17-dion (xxxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxx-3,5-xxxx-7,17-xxxx (xxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
4.2.&xxxx;XXXXXXXXXXXXXX LÁTKY (XXXXXXXXXXXXX X XXXXXXXXXX MODULÁTORY XXXXXXXXXXXXX XXXXXXXXX (XXXXX))
Xxxxxx, xxx ne x xxxxxxxx xxxxx xx xx:
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
4.3.&xxxx;XXXXX XXXXXXXXXXX AKTIVACI XXXXXXXXX AKTIVINU XXX
Xxxxxx, xxx xx x xxxxxxxx pouze na xx:
•&xxxx;xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxx X;
•&xxxx;xxxxxxxxxx receptory xxxxxxxx XXX xxxx xxxxxxxxx:
-&xxxx;xxxxxxx xxxxxxxxx xxxxxxxx, např. XXX-031;
•&xxxx;xxxxxxxxxx proti receptoru xxxxxxxx IIB, xxxx. xxxxxxxxxx;
•&xxxx;xxxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx:
-&xxxx;xxxxx xxxxxxxxxx xxxx xxxxxx xxxxxxx xxxxxxxxxx;
-&xxxx;xxxxxxxx xxxxxx xxxxxxxxx, xxxx. xxxxxxxxxxx, xxxxxxxxxxxxxxxxxx;
-&xxxx;xxxxxxxxxx neutralizující xxxxxxxxx, xxxx. xxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxx.
4.4.&xxxx;XXXXXXXXXXX XXXXXXXXXX
4.4.1&xxxx;xxxxxxxxxx AMP-aktivované xxxxxxxxxxxxx (XXXX), xxxx. AICAR, XX9009 x xxxxxxxx xxxxxxxxx 5 xxxxxxxxxxxx xxxxxxxxxxxxxx proliferáty (PPARα), 2-(2-xxxxx-4-((4-xxxxx-2-(4-(xxxxxxxxxxxxxx)xxxxx)xxxxxxx-5-xx)xxxxxxxxx)xxxxxxx) xxxxxxxx octová (XX1516, XX501516);
4.4.2&xxxx;xxxxxxxx x xxxxxxxx insulinů;
4.4.3 meldonium;
4.4.4 trimetazidin.
S5 DIURETIKA X XXXXXXXXX XXXXX
XXXXXXXX XXXXX (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxx xxxxxxxx xxxxx v xxxx xxxxxxxxx jsou xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxx xxxxxxxxx x xxxxxxxxx xxxxx, xxxxxx xxxxxx xxxxxxxxxx xxxxx optických xxxxxxx, xxxx.&xxxx;x-&xxxx;x&xxxx;x-, xxxx xxxxxxxx.
Xxxxxx, ale xx x xxxxxxxx pouze xx xx:
•&xxxx;xxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxxxxxx, xxxx. xxxxxxxxxx xxxxxx albuminu, dextranu, xxxxxxxxxxx škrobu x xxxxxxxxx;
•&xxxx;xxxxxxxxxxxx; amilorid; xxxxxxxxx; xxxxxxxxx; xxxxxxxxxxxx; xxxxxxxxx; xxxxxxxx; xxxxxxxx xxxxxxxxxx; xxxxxxxxx; xxxxxxxxxxxxx; thiazidy, xxxx. bendroflumetiazid, hydrochlorothiazid x chlorothiazid; torasemid, xxxxxxxxxx a xxxxxxx, xxxx. xxxxxxxxx.
X další xxxxx x podobnou xxxxxxxxx xxxxxxxxxx nebo xxxxxxxxx xxxxxxxxxxxx xxxxxx.
XXXXXXX
•&xxxx;xxxxxxxxxxx; xxxxxxxx a lokální xxxx podání xxxxxxxxxxxxxx, xxxx. xxxxxxxxxxx, xxxxxxxxxxxx);
•&xxxx;xxxxxxx xxxxxx xxxxxxxxxxxx xxx xxxxx xxxxxxxxx.
! XXXXXXXX
Xxxxx xxxxxxxxxxx množství xxxxx xx stanoveným xxxxxxxx xxxxxxx, tj. u xxxxxxxxxxx, xxxxxxxxxxx, xxxxxx, xxxxxxxx, xxxxxxxxxxxxx a xxxxxxxxxxxxxx xx&xxxx;Xxxxxx Sportovce kdykoliv xxxx xxxxxxxx&xxxx;Xxx Xxxxxxx&xxxx;xx xxxxxxx s xxxxxxxxxx xxxx xxxxx xxxxxxxxx xxxxxx (xxxxx lokálního xxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxxxxxx nebo xxxxxxxxx xxxxxx xxxxxxxxxxx x xxxxxxxx xxxxxxxxx), xxxx xxxxxxxxx xx&xxxx;Xxxxxxxxx laboratorní xxxxx (AAF), pokud Sportovec nemá xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx výjimku (XX)&xxxx;xx xxxx xxxxx navíc x té, která xxx xxxx xxxxxxx xx xxxxxxxxxx nebo xxxxx xxxxxxxxx xxxxx.
XXXXXXXX XXXXXX
XXXXXXXX XXXXX (XXX XXXXXXX X XXXX XXXXXX)
Xxxxxxx xxxxxxxx metody x této xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxxxx xxxxxx, xxxxx xxxxx x M2.2., xxx xxxx&xxxx;Xxxxxxxxxx xxxxxx.
X1.&xxxx;XXXXXXXXXX S XXXX X XXXXXXXX XXXXXXXXXXXX
Xxxxxxxx je xxxxxxxxxxx:
1.&xxxx;Xxxxxx&xxxx;xxxx xxxxx zavedení jakéhokoliv xxxxxxxx xxxxxxxxx, alogenní (xxxxxxxxx) nebo xxxxxxxxxxx xxxx, xxxx xxxxxxxxx xxxxxxx a jim xxxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx oběhového xxxxxxx.
2.&xxxx;Xxxxx xxxxxxxxx spotřeby, xxxxxxx xxxx dodávky xxxxxxx. Včetně, xxx xx s xxxxxxxx xxxxx na xx:
xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxx (XXX13), xxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxxxx produkty, xxxx. xxxxxx náhražky xxxxxxxx xx xxxxxxxxxxx x xxxxxxxxxxxxxxxxxx xxxxxxxxxxx, xxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxx.
3.&xxxx;Xxxxxxxxx xxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x xxxx xxxx x krevními xxxxxxxxxxxx xxxxxxxxxxx xxxx chemickými xxxxxxx.
X2.&xxxx;XXXXXXXX X FYZIKÁLNÍ XXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
1.&xxxx;Xxxxxxxxx, xxxx&xxxx;Xxxxx&xxxx;x&xxxx;Xxxxxx, xx xxxxxx xxxxxxx xxxxxxxxx a xxxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx xxx&xxxx;Xxxxxxxxx xxxxxxxx.
Xxxxxx, xxx ne s xxxxxxxx xxxxx xx xx:
Xxxxxx x/xxxx úprava Vzorku, xxxx. přidáním proteáz xx&xxxx;Xxxxxx.
2.&xxxx;Xxxxxxxxxx xxxxxx x/xxxx xxxxxxx xxxx xxx xxxxxx 100 xx xx 12 xxxxx xxxxx xxxxxx legitimně xxxxxxxxx v průběhu xxxxxxxxxxxx xxxxxxxx, chirurgických xxxxxxx nebo xxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxx.
X3.&xxxx;XXXXXX X XXXXXXX XXXXXX
X xxxxxx xxxxxxxxxxxxxxx zvýšení sportovního xxxxxx xx xxxxxxxx xxxxxxxxxxx:
1.&xxxx;Xxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxx xxxxxxx, xxxxx xxxxx xxxxxx xxxxxxxx xxxxxx x/xxxx xxxxxxx genu xxxxxxxxxx xxxxxxxxxxx. Xx zahrnuje, xxx není xxxxxxx xxxxx xx xxxxxxxxxxx xxxxx xxxx, xxxxxxxxx xxxx a technologie xxxxxxx xxxx.
2.&xxxx;Xxxxxxx normálních xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx.
X6 XXXXXXXXXXX
XXXXXXXX XXX XXXXXXX
Xxxxxxx xxxxxxxx xxxxx x této xxxxxxxxx xxxx považovány za Specifické xxxxx, xxxxx xxxxx xxxxxxxxx x S6.A, xxx jsou Nespecifické xxxxx.
Xxxxxxxx xxxxx&xxxx;x xxxx xxxxxxxxx xxxx: kokain a xxxxxxxxxxxxxxxxxxxxxxxx (XXXX/"xxxxxx").
Xxxxxxx xxxxxxxxxxx xxxxxx xxxxx xxxxxx xxxxxxxxxx xxxxxxxxx isomerů, xxxx.&xxxx;x-&xxxx;x&xxxx;x-, xxxx xxxxxxxx. Xxxxxxxxxxx xxxxxxxx:
X: XXXXXXXXXXXX XXXXXXXXXXX
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxx xxxxxxx [4-fenylpiracetam (xxxxxxxxx)]
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx(x-)
•&xxxx;x-xxxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
Xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx x této xxxxxxxxx, xx&xxxx;Xxxxxxxxxxx xxxxxx.
X: XXXXXXXXXX XXXXXXXXXXX
Xxxxxx, xxx xx x xxxxxxxx xxxxx na xx:
•&xxxx;3-xxxxxxxxxx-2-xxxx (1,2-xxxxxxxxxxxxxxxxx)
•&xxxx;4-xxxxxxxxxxxxxxxxxx
•&xxxx;4-Xxxxxxxxxxx-2-xxxxx (xxxxxxxxxxxxxxxxx, 1.3-dimethylamylamine, 1,3 DMAA)
• 4-metylpentan-2-amin (1,3-xxxxxxxxxxxxxxxx)
•&xxxx;5-Xxxxxxxxxxx-2-xxxxx (1,4-xxxxxxxxxxxxxxxxxxx, 1.4-xxxxxxxxxxxxxxxxx, 1.4-XXXX)
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxx (xxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxx***
•&xxxx;xxxxxxxxx (xxxxxxxxx)****
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx a xxxx deriváty
• fenkamfamin
• fenmetrazin
• fenprometamin
• heptaminol
• hydrafinil (xxxxxxxxx)
•&xxxx;xxxxxxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxx**
•&xxxx;xxxxxxx x jeho xxxxxxx, např. mefedron, xxxxxxxx x α-xxxxxxxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx***
•&xxxx;xxxxxxxxxxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx [((±)-xxxxx-2-(xxxxxxxx-2-xx)-2-(xxxxxxxxx-2-xx)xxxxxx]
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxx (1,5-xxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxx (metylsynefrin)
• pemolin
• pentetrazol
• propylhexedrin
• pseudoefedrin*****
• selegilin
• sibutramin
• solriamfetol
• strychnin
• tenamfetamin (xxxxxxxxxxxxxxxxxxxxx)
•&xxxx;xxxxxxxxxxxxx
x další látky x podobnou xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.
VÝJIMKY
• klonidin;
• deriváty imidazolinu x xxxxxxx jejich xxxxxxx, xxxxxxx, očního xxxx xxxxxx xxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxx, xylometazolin) x stimulancií xxxxxxxxxx xx Monitorovacího xxxxxxxx xxx xxx 2023*.
* xxxxxxxxx, fenylefrin, xxxxxxxxxxxxxxxxx, xxxxxx, xxxxxxx, pipradrol x xxxxxxxx: xxxx xxxxx xxxx xxxxxxxx xx Monitorovacího xxxxxxxx 2023 x xxxxxx xxxxxxxxxx xx&xxxx;Xxxxxxxx látky.
** xxxxx (x-xxxxxxxxxxxxxxxx) a xxxx x-xxxxxxx: je xxxxxxxx pouze xxx xxxxxxxxxxx xxxxx xxx 5 mikrogramů v 1 xx moči.
*** efedrin xxx xxxxxxxxxxxx: jsou xxxxxxxx při koncentraci xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.
****&xxxx;xxxxxxxxx (xxxxxxxxx): xxxx xxxxxxx xxx xxxxxxxx podání, xxxx. xxxxx, xxxx aplikace xxxx jeho podání xxxxxxxx x xxxxxxxxx xxxxxxxxxx.
*****&xxxx;xxxxxxxxxxxxx: xx xxxxxxx, xxxxx xx xxxx xxxxxxxxxxx vyšší xxx 150 xxxxxxxxxx na xx moči.
S7 NARKOTIKA
ZAKÁZANÉ XXX SOUTĚŽI
Všechny xxxxxxxx xxxxx v xxxx xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxxxxxx xxxxx&xxxx;x xxxx xxxxxxxxx xxxx: xxxxxxxxx (xxxxxx).
Xxxxxxxxxxx xxxxxxxxx, xxxxxx xxxxxx případných xxxxx xxxxxxxxx isomerů, xxxx.&xxxx;x-&xxxx;x&xxxx;x-&xxxx;xxxx zakázaná.
• buprenorfin
• dextromoramid
• diamorfin (xxxxxx)
•&xxxx;xxxxxxxx x jeho deriváty
• hydromorfon
• metadon
• morfin
• nikomorfin
• oxykodon
• oxymorfon
• pentazocin
• petidin
S8 XXXXXXXXXXX
XXXXXXXX XXX SOUTĚŽI
Všechny xxxxxxxx xxxxx x xxxx xxxxxxxxx jsou xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.&xxxx;Xxxxxxxx xxxxx&xxxx;x xxxx kategorii xxxx: tetrahydrokanabinol (XXX).
Xxxxxxx xxxxxxxx a xxxxxxxxxx xxxxxxxxxxx xxxx xxxxxxxx, xxxx.
•&xxxx;x konopí (hašiš, xxxxxxxxx) a konopných xxxxxxxxxx;
•&xxxx;xxxxxxxx x xxxxxxxxxx xxxxxxxxxxxxxxxxxxxxx (XXX);
•&xxxx;xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxx xxxxxx THC.
VÝJIMKY
• kanabidiol
S9 XXXXXXXXXXXXXXX
XXXXXXXX XXX SOUTĚŽI
Všechny xxxxxxxx látky x xxxx xxxxxxxxx xxxx xxxxxxxxxx za Specifické látky.
Všechny xxxxxxxxxxxxxxx podávané xxxxxxxx, xxxxxxxx nebo xxxxxxxxx (xxxxxx xxxx. xxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx) xxxx xxxxxxxx.
Xxxxxx, ale xx x xxxxxxxx pouze xx xx:
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxx xxxxxxxx
! XXXXXXXX
•&xxxx;Xxxx xxxxxxx xxxxxx (xxxxxx xxxxxxxxxxx a xxxxxxxxx: xxxxxxxx-xxxxxxxxxxxx, xxxxxxxx, xxxxxxxxxxxx, xxxxxxxxxxxxxx, xxxx x xxxxxxxxxx) xxxxxx xxxxxxxx, pokud jsou xxxxxxxxx x xxxxx xxxxxxxxxxxx dávek x xxxxxxxxxxxxxx xxxxxxxx xxxxxxxx.
X1 XXXX-XXXXXXXXX
XXXXXXXX X XXXXXXXX XXXXXXXX
Xxxxxxx zakázané xxxxx x této xxxxxxxxx xxxx xxxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxx.
Xxxx-xxxxxxxxx xxxx xxxxxxxx xxxxx x xxxxxxxxxxxxx xxxxxxxx&xxxx;Xxx Xxxxxxx&xxxx;x xxx xx xx xxxxxxxx xxxxxxxx (*) x&xxxx;Xxxx xxxxxx.
•&xxxx;xxxxxxxxxxxx xxxxx (FIA)
• biliard (xxxxxxx disciplíny) (XXXX)
•&xxxx;xxxx (XXX)
•&xxxx;xxxxxxxxxxx (XX)*
•&xxxx;xxxx-xxxx (XXX)
•&xxxx;xxxxxxx (XXXX, XXX)*
•&xxxx;xxxxx (WDF)
• lyžování/snowboarding (XXX) - xxxxx xx lyžích, xxxxxxxxxxx xxxxxxxx xxxxx/X-xxxxx x xxxxxxxxx X-xxxxx/"xxx xxx"
•&xxxx;xxxxxxxx xxxxxx (CMAS) v xxxxxxxxxxxx xxxxxxx xxxxxxxx, xxxx xxx xx xxxxxx x xxxxxxx xx xxxx
*&xxxx;xxxxxxxx xxxx&xxxx;Xxxx xxxxxx.
Xxxxxx, xxx xx x xxxxxxxx pouze xx xx:
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxxxx
•&xxxx;xxxxxxxxxx
•&xxxx;xxxxxxxx
•&xxxx;xxxxxxxxxxx
•&xxxx;xxxxxxx
•&xxxx;xxxxxxx
XXXXXXXX
(±)-Xxxxxx-2-(xxxxxxxxxx-2-xx)-2-(xxxxxxxxx-2-xx)xxxxxxx, 15
1-Xxxxxxxxxxxxxx, 5
1-Xxxxxxxxxxxxxxx, 5
1-Androsterone, 5
1-Epiandrosterone, 5
1-Xxxxxxxxxxxx, 5
1.2-Xxxxxxxxxxxxxxxxxxx, 15
[1,2]Xxxxxxx[4’,5’:2,3]xxxxxx-4-xx-20-xx-17α-xx), 5
1.3-Xxxxxxxxxxxxxxxxx (1,3 XXXX), 15
1.3-Xxxxxxxxxxxxxxxxxx, 15
1.4-Xxxxxxxxxxxxxxxxx (1,4-DMAA), 15
1.4-Xxxxxxxxxxxxxxxxxxx, 15
1.5-Xxxxxxxx-xxxxxxxxxx, 15
2-Xxxxxxxxxxx, 10
2-Xxxxxxxxxxxx, 10
3α-Xxxxxxx-5α-xxxxxxx-1-xxx-17-xxx, 5
3ß-Xxxxxxx-5α-xxxxxxx-1-xxx-17-xxx, 5
3ß-Xxxxxxx-5α-xxxxxxxxx-17-xxx, 5
3ß-Hydroxyandrost-5-en-17-one, 6
3-Androstenol, 10
3-Xxxxxxxxxxxx, 10
3-Methylhexan-2-amine, 15
4-Xxxxxxxxxx-3,6,17 xxxxxx, 10
4-Androstenediol, 5
4-Chloro-17ß-hydroxy-17α-methylandrosta-1,4-dien-3-one, 5
4-Xxxxxx-17ß-xx-xxxx-4-xx-3-xxx, 6
4-Fluoromethylphenidate, 15
4-Hydroxytestosterone, 5
4-Xxxxxxxxxxx-2-xxxxx, 15
4-Xxxxxxxxxxxx-2-xxxxx, 15
4-Phenylpiracetam, 14
4,17ß-Xxxxxxxxxxxxxxxx-4-xx-3-xxx, 5
5α-Xxxxxxx-1-xxx-3, 17-xxxxx, 5
5α-Xxxxxxx-1-xxx-3ß, 17ß-xxxx, 5
5α-Androst-2-en-17-ol, 10
5α-Xxxxxxx-2-xx-17-xxx, 10
5α-Xxxxxxx-3-xx-17-xx, 10
5α-Xxxxxxx-3-xx-17-xxx, 10
5α-Xxxxxxxxxxxxxxxxxxx, 5
5-Xxxxxxxxxxxxxxx, 5
5-Methylhexan-2-amine, 15
6-Xxx, 10
7α-Xxxxxxx-XXXX, 5
7ß-Hydroxy-DHEA, 5
7-Xxxx-XXXX, 5
11-Xxxxxxxxxxxxxxxxxxx, 5
17α-Xxxxxx[1,2,5]xxxxxxxxxx[3’,4’:2,3]-5α-xxxxxxxxx-17ß-xx, 5
17α-Xxxxxx-5α-xxxxxxx-2-xx-17ß-xx, 5
17α-Xxxxxx-5α-xxxxxxx-3-xx-17ß-xx, 5
17α-Xxxxxxxxxxxxxxxxxxx, 5
17ß-Xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xxx, 6
17ß-Hydroxy-5α-androst-1-en-3-one, 5
17ß-Xxxxxxx-5α-xxxxxxxxx-3-xxx, 5
17ß-Xxxxxxx-5ß-xxxxxxxxx-3-xxx, 5
17ß-xxxxxxx-17α-xxxxxx-5α-xxxxxxx-1-xx-3-xxx, 6
17ß-Xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xxx, 6
17ß-Xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xxx,6
17ß-Xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xxx, 6
17ß-Xxxxxxx-17α-xxxxxxxxxxx-4,9,11- xxxxx-3-xxx, 6
17ß-Xxxxxxxxxxx-4,9,11-xxxxx-3-xxx, 6
17ß-[(Xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx, 6
17-Xxxxxxx-18x-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xxx, 6
19-Xxxxxxxxxxxxxxxxx, 5
19-Norandrostenedione, 5
19-Norpregna-4-en-17α-ol, 5
19-Xxxxxxxxxxxxxxx, 6
x-Xxxxxxxxxxxxxxxxxxxxxxxx, 15
A
ACE-031, 11
Xxxxxxxxxx, 19
Acetazolamide, 12
Xxxxxxx X-xxxxxxxxxxxx xxxxxxxxxx, 11
Xxxxxxx xxxxxxxx IIB competitors, 11
Xxxxxxxxx, 14
Xxxxxxxxxx, 15
Adrenosterone, 5
XXXXX, 11
Xxxxxxx, 12
Alexamorelin, 8
Xxxxxxxxxx, 19
Amfepramone, 14
Xxxxxxxxxx, 14
Xxxxxxxxxxx, 14
Xxxxxxxxx, 12
Xxxxxxxxxxxxxxxxx, 10
Xxxxxxxxxxxx, 14
AMP-activated xxxxxxx xxxxxx (AMPK), 11
Anamorelin, 8
Xxxxxxxxxxx, 10
Xxxxxxxx, 6
Xxxxxxx-4-xxx-3ß,17ß-xxxx, 5
Xxxxxxx-4-xxx-3,11,17- xxxxxx, 5
Androst-4-ene-3,17-dione, 5
Xxxxxxx-5-xxx-3ß,17ß-xxxx, 5
Androst-5-ene-3,17-dione, 5
Xxxxxxxx-1,4,6-xxxxxx-3,17-xxxxx, 10
Xxxxxxxx-1,4-xxxxx-3,17-xxxxx, 5
Xxxxxxxx-3,5-xxxxx-7,17-xxxxx, 10
Xxxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxxxxxxx, 10
Xxxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxxx, 5
Xxxx-xxxxxxx receptor IIB xxxxxxxxxx, 11
AOD-9604, 7
Xxxxxxxxxxx, 11
Xxxxxxxxxxxx, 9
Arimistane, 10
Asialo XXX, 7
Atenolol, 19
B
Bazedoxifene, 10
Xxxxxxxxxxxxx, 18
Xxxxxxxxxxxxxxxxxxx, 12
Xxxxxxxxxx, 14
Xxxxxxxxxxxx, 15
Benzylpiperazine, 14
Betamethasone, 18
Xxxxxxxxx, 19
Bimagrumab, 11
Xxxxxxxxxx, 19
Xxxxx, 13
Xxxxx (xxxxxxxxxx), 13
Xxxxx (xxxxxxxxxx), 13
Xxxxx (xxxxxxxxxxxx), 13
Blood (homologous), 13
Xxxxx xxxxxxxxxxxx, 13
Bolasterone, 5
Xxxxxxxxx, 5
Xxxxxxxx, 5
XXX-157, 4
Xxxxxxxxxxx, 15
Brinzolamide, 12
Xxxxxxxxx, 14
Xxxxxxxxxx, 18
Bumetanide, 12
Xxxxxxx, 19
Xxxxxxxxxxxxx, 16
Buserelin, 8
C
Calusterone, 5
Xxxxxxxxxxx, 17
Cannabis, 17
Xxxxxxxxx, 12
Xxxxxxxxxxxx EPO (XXXX), 7
Xxxxxxxxx, 14
Xxxxxxxxx, 19
Carvedilol, 19
Xxxxxxx, 12,15
Cathinone, 15
Celiprolol, 19
Xxxx (xxxxxx), 13
Xxxx (xxxxxxxxxxx modified), 13
Cell (xxxxxx), 13
Xxxx (xxx xxxxx), 13
Xxxxxxxxxxxxxx, 12
Xxxxxxxxxxxxx, 12
Xxxxxxxxx Xxxxxxxxxxxxx (XX), 8
Xxxxxxxxxxx, 18
XXX-1293, 8
XXX-1295, 8
Xxxxxxxxxxx, 6
Xxxxxxxxxxx, 14
Clomifene, 10
Xxxxxxxxxxx, 15
Xxxxxxxxx, 15
Xxxxxxxxx, 5
XXXX-530, 7
Xxxxxx, 7
Cocaine, 14
Xxxxxxxxxxxx, 8
Xxxxxxxxxxxxxxx, 8
Cortisone, 18
Xxxxxxxxxxxx, 14
Crotetamide, 14
Cyclofenil, 10
X
Xxxxxxx, 5
Xxxxxxxxxxx, 7
Xxxxxxxxxxxx (xXXX), 7
Xxxxxxxxxxx, 18
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxxxxxxxxxx (XXXX), 6
Xxxxxxxxxx, 8
Xxxxxxxxxxxx, 12
Xxxxxxxxxxxxxxxxxxxxxxxx, 5
Dexamethasone, 18
Xxxxxxx, 12
Xxxxxxxxxxxxxx, 16
Diamorphine, 16
Xxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxx, 11
Xxxxxxxxxxx, 12
Xxxxxxxxxxxx, 12
Xxxxxxxxxxxx, 5
X
Xxxxxxx, 14
Xxxxxxxxxxx (XXX13), 13
Xxxxxxxxx, 6
Ephedrine, 12,15
Xxxxxxxxxxxxxxx, 5
Xxx-xxxxxxxxxxxxxxxxxxx, 5
Xxxxxxxxxxx, 15
Xxxxxxxx, 5
Xxxxxxxxxxxxxxx, 5
XXX-xxxxx constructs, 7
XXX-Xx, 7
XXX-xxxxxxx xxxxxx, 7
Xxxxxxxxxxxxxx xxxxxxxx agonists, 7
Xxxxxxxxxxxxxxx (XXX), 7
Xxxxxxx, 19
Xxxx-4-xxx-3,17-xxxx, 5
Xxxx-4-xxx-3,17-xxxxx, 5
Etacrynic xxxx, 12
Xxxxxxxx, 15
Xxxxxxxxxxxxx, 5
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxx, 15
Xxxxxxxxxx, 8
Exemestane, 10
X
Xxxxxxxxxxxx, 15
Xxxxxxxxxxx, 12
Xxxxxxxxxxxx, 15
Xxxxxxxxxxx, 15
Xxxxxxxxx, 14
Xxxxxxxxxxx, 14
Xxxxxxxxxxxx, 14
Xxxxxxxxx, 9
Fenoxazoline, 15
Xxxxxxxxxxx, 14
Xxxxxxxx, 16
Xxxxxxxxxx xxxxxx xxxxxxx (XXXx), 8
Xxxxxxxxxxx, 18
Xxxxxxxxxxxxx, 18
Xxxxxxxxx, 15
Fluoxymesterone, 5
Xxxxxxxxxxx, 18
Follistatin, 11
Xxxxxxxxxxxx, 14
Xxxxxxxxxxx,5
Xxxxxxxxxx, 10
Xxxxxxxxxx, 9, 12
Xxxxxxxxxxx, 10
Xxxxxxxxx, 5
Xxxxxxxxxx, 14
Xxxxxxxxxx, 12
G
GATA xxxxxxxxxx, 7
Xxxx doping, 13
Xxxx xxxxxxx, 13
Xxxx xxxxxxxxx, 13
Xxxx transfer, 13
Xxxxxxxxxx, 5
Xxxxxxx, 8XX-xxxxxxxxx peptides (XXXXx), 8
Xxxxxxxxxxx, 8
Xxxxxxxxx, 8
Xxxxxx xxxxxxx (XX), 8
Xxxxxx hormone xxxxxxxxxxxxx (XXX), 8
XX1516,1
XX501516, 11
H
Haemoglobin (xxxxxxxx), 13
Xxxxxxxxxxx (xxxxx xxxxx substitutes), 13
Xxxxxxxxxxx (xxxxxxxxxxxxxxxxx xxxxxxxx), 13
Hashish, 17
Xxxxxxxxxx xxxxxx factor (XXX), 8
Heptaminol, 15
Xxxxxx, 16
Xxxxxxxxx, 8
xXX 176-191, 8
Xxxxxxxxxx, 9
Xxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxxx, 12
Xxxxxxxxxxxxxx, 18
Xxxxxxxxxxxxx, 16
Hydroxyamfetamine, 15
Xxxxxxxxxxxx xxxxxx, 12
Hypoxia-inducible xxxxxx (XXX) activating xxxxxx, 7
X
Xxxxxxxxxxx, 15
Xxxxxxxxxxx, 9
Xxxxxxxxxxxx, 15
Xxxxxxxxxx, 12
Xxxxxxxxx, 13
Xxxxxxxxxx (>100 xX), 13
Xxxxxx xxxxxx xxxxxxxx xxxxxxxx, 7
Insulin-like xxxxxx xxxxxx-1 (IGF-1), 8
Xxxxxxx-xxxxxxxx, 11
Xxxxxxxx, 11
Xxxxxxxxxxx xxxxxxxxx/xxxxxxxxxx, 13
XXX2, 7 Xxxxxxxxxx, 8
Xxxxxxxxxxxxx, 15
X
X-11706, 7
L
Labetalol, 19
Xxxxxxxxxxxxx, 11
Xxxxxxxxxxx, 8
Xxxxxxxxx, 10
Xxxxxxxxxxx, 8
Levmetamfetamine, 15
Xxxxxxxxxxxxxx, 9
XXX-4033, 6
Xxxxxxxxx, 6
Lisdexamfetamine, 14
Xxxxxxxxxxxxxxxxx, 8
Xxxxxxxxxxxx, 7
Xxxxxxxxxxx xxxxxxx (LH), 8
X
Xxxxxxxxxxx, 8
Xxxxxxxx, 12
Xxxxxxxxx, 17
Mechano xxxxxx factors (XXXx), 8
Xxxxxxxxxxxxx, 15 Mefenorex, 14
Xxxxxxxxx, 11
Mephedrone, 15
Mephentermine, 14
Xxxxxxxx, 14
Mestanolone, 6
Xxxxxxxxxxx, 6
Xxxxxxxxxxxxx(x-), 14
Metandienone, 6
Xxxxxxxxxx, 6
Xxxxxxxxx, 16
Xxxxxxxxxxx, 6
Xxxxxxxxxxxx, 6
Xxxxxxxxxx, 15
Xxxxxxx xxxxxxxxxxxx xxxxxx-xxxxxxx xxxx (CERA), 7
Xxxxxx-1-xxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxx, 6
Methyldienolone, 6
Xxxxxxxxxxxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxx, 15
Methylephedrine, 12, 15
Xxxxxxxxxxxxxxxxx, 15
Methylnaphtidate, 15
Xxxxxxxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxx, 18
Xxxxxxxxxxxxxxxx, 15
Methyltestosterone, 6
Xxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxxx, 19
Xxxxxxxxxx, 12
Xxxxxxxxxx, 19
Xxxxxxxxxxx, 6
Mibolerone, 6
Modafinil, 14
Xxxxxxxxxx, 7
Xxxxxxxxxx, 18
Xxxxxxxx, 16
Xxxxxxxxx xxxxxxxxxx, 11
Xxxxxxxxx xxxxxxxxx-xxxxxxxxxxxx xxxxxxxxxx, 11
Myostatin xxxxxxxxxx, 11
Myostatin-binding xxxxxxxx, 11
Xxxxxxxxx-xxxxxxxxxxxx xxxxxxxxxx, 11
X
Xxxxxxx, 19
Xxxxxxxxx, 8
Nandrolone, 6
Xxxxxxxxxxx, 15
Xxxxxxxxx, 19
Nicomorphine, 16
Nikethamide, 15
Xxxxxxxxxxx, 6
Norclostebol, 6
Norethandrolone, 6
Xxxxxxxxxxxx, 15
Norfenfluramine, 14
Nucleic xxxxx, 13
Xxxxxxx acid xxxxxxxxx, 13
O
Octodrine, 15
Xxxxxxxxxx, 15
Xxxxxxxxxx, 9
Xxxxxxxxxxxx, 6
Xxxxxxxxxx, 10
Xxxxxxxx, 6
Xxxxxxxxx, 6
Xxxxxxxxxxx, 6
Xxxxxxxxxx, 15
Xxxxxxxxxx, 19
Xxxxxxxxx, 16
Xxxxxxxxxxxx, 6
Xxxxxxxxxxxxx, 15
Oxymetholone, 6
Xxxxxxxxxxx, 16
X
Xxxxxxxx, 12
Xxxxxxxxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxxx, 7
Xxxxxxxx, 15
Xxxxxxxxxxx, 16
Xxxxxxxxxxx, 15
Xxxxxxxxxxxxxxxxxx, 13
Xxxxxxxxxx xxxxxxxxxxxx xxxxxxxxx xxxxxxxx xxxxx xxxxxxxx, 11
Pethidine, 16
Xxxxxxxxxxxxxxx, 14
Xxxxxxxxxxxxxx, 15
Phenmetrazine, 15
Xxxxxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 14
Xxxxxxxx, 19
Xxxxxx xxxxxxxxx, 12
Platelet-derived xxxxxx xxxxxx (PDGF), 8
x-xxxxxxxxxxxxxxxx, 14
Xxxxxxxxxxx, 8
Xxxxxxxxxx, 6
Xxxxxxxxxxxx, 18
Xxxxxxxxxx, 18
Xxxxxxxxxxx, 14
Xxxxxxxxxx, 12
Procaterol, 9
Prolintane, 14
Xxxxxxxxxxx, 19
Xxxxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 6
Xxxxxxxxx, 13
Xxxxxxxxxxxxxxx, 12, 15
X
Xxxxxxxxxx, 6
X
XXX140, 6
Xxxxxxxxxxx, 6
Xxxxxxxxxx, 10 , 9
Xxxxxxxxxx, 7
X
X-23, 6
Salbutamol, 9, 12
Xxxxxxxxxx, 9
Xxxxxxxxx xxxxxxxx receptor xxxxxxxxxx (XXXXx), 6
Xxxxxxxxxx, 15
Xxxxxxxxxx, 8
Xxxxxxxxxxx, 15
Xxxxxxxxxxxx, 15
Somapacitan, 8
Xxxxxxxxxx, 8
Xxxxxxx, 19
Xxxxxxxxxxx, 7
Xxxxxxxxxxxxxx, 12
XX9009, 11
Xxxxxxxxxx, 11
Xxxxxxxxxx, 6
Xxxxxxxxxx, 6
Xxxxxxxxxx, 15
X
Xxxxxxxxxxx, 8
Tamoxifen, 10
Xxxxxxxxx, 13
XX-500, 8
Xxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 9
Xxxxxxxxxxx, 8
Xxxxxxxxxxxx, 10
Testosterone, 6
Xxxxxxxxxxxxxxxxxxxxx, 17
Xxxxxxxxxxxxxxxxxxxx, 6
Xxxxxxxxxxx, 15
Xxxxxxxxx, 12
Xxxxxxxx-154, 8
Tibolone, 6
Xxxxxxx, 19
Xxxxxxxxx, 12
Xxxxxxxxxx, 12
Xxxxxxxxxx, 10
Xxxxxxxxxxxx xxxxxx xxxxxx xxxx (TGF-ß) xxxxxxxxxx inhibitors, 7
Trenbolone, 6
Xxxxxxxxxxx, 9
Triamcinolone xxxxxxxxx, 18
Xxxxxxxxxxx, 12
Xxxxxxxxxxxxx, 11
Xxxxxxxxxxxxx, 9
Xxxxxxxxxxx, 8
Xxxxxxxxxxxxxx, 15
Xxxxxxxxxxx, 9
X
Xxxxxxxxxx (XXX-6548), 7
Xxxxxxx, 12
Xxxxxxxx xxxxxxxxxxx xxxxxx xxxxxx (VEGF), 8
Xxxxxxxxxx, 9
Xxxxxxxxx, 13
X
Xxxxx, 7
Xxxxxxxxxxxxxx, 15
X
XX-11, 6
X
Xxxxxxx, 6
Xxxxxxxxxx, 6
XXXXXXX XXXXXXXXXXXXX KODEX
MEZINÁRODNÍ
STANDARD
PRO XXXXXXXXXXXX XXXXXXX
2023
Xxxxxxxxxxx standard xxx Terapeutické xxxxxxx
Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;x rámci Xxxxxxxxx xxxxxxxxxxxxxxx&xxxx;Xxxxxx&xxxx;xx xxxxxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxxx jako xxxxxxx Xxxxxxxxx xxxxxxxxxxxxxxx programu. Xxx xxxxxxxx xx xxxxxxxxxx xx&xxxx;Xxxxxxxxx, veřejnými xxxxxx x dalšími xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxx.
Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxx xxxxxx xxxxxx x xxxx 2004 x xxxxx xxxxxxxxx 1. ledna 2005. Xxxxxxxx xxx xxxxxxxx xxxxxxxxxxx, xxxxxx x xxxxxxxxx xx xxxxx 2009, podruhé x xxxxxxxxx xx xxxxx 2010, xxxxxxx x xxxxxxxxx od xxxxx 2011, xxxxxxxx x účinností xx xxxxx 2015, popáté x xxxxxxxxx xx xxxxx 2018, xxxxxxx x xxxxxxxxx xx xxxxx 2019, posedmé x účinností od xxxxx 2021. Xxxx xxxxxxxxxx xxxxx xxxx xxxxxxxxx XX&xxxx;XXXX&xxxx;23. září 2022 a je xxxxxx od 1. xxxxx 2023.
&xxxx;
Xxxxxx:
XXXX
Xxxxx Xxxxxxxx Xxxxx
800 Place Victoria (Xxxxx 1700)
XX Xxx 120
Xxxxxxxx, Xxxxxx
Xxxxxx H4Z 1X7
Xxx: + 1 514 904 9232
Xxx: + 1 514 904 8650
X-xxxx: xxxx@XXXX-xxx.xxx
&xxxx;
XXXXX
|
XXXXX XXXX: ÚVOD, XXXXXXXXXX&xxxx;XXXXXX, XXXXXXXXXX&xxxx;XXXXXXXXXXXXX XXXXXXXXX&xxxx;X XXXXXXXX |
|
|
1.0 |
Xxxx x působnost |
|
2.0 |
Ustanovení Kodexu |
|
3.0 |
Definice a xxxxxx xxxxx |
|
XXXXX ČÁST: XXXXXXXXX X XXXXXX XXX XXXXXXXXX&xxxx;XX |
|
|
4.0 |
Xxxxxxxxx&xxxx;XX. |
|
5.0 |
Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx xx&xxxx;XX |
|
6.0 |
Xxxxxx při xxxxxxxx xxxxxxx x&xxxx;XX |
|
7.0 |
Xxxxxx xxx xxxxxxxx&xxxx;XX |
|
8.0 |
Xxxxxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxxx XXXX |
|
9.0 |
Xxxxxxxxx xxxxxxxxx |
|
XXXXXXX 1: Postupový xxxxxxx xxx článku 4.4 Kodexu |
|
ČÁST XXXXX: ÚVOD, XXXXXXXXXX XXXXXX, MEZINÁRODNÍHO STANDARDU X XXXXXXXX
1.0&xxxx;Xxxx x xxxxxxxxx
Xxxxxxxxxxx xxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky je xxxxxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxxx xxxx xxxxxxx Xxxxxxxxx antidopingového xxxxxxxx.
Xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xx xxxxxxxx (a) podmínky, xxxxx xxxx xxx xxxxxxx, aby xxxx xxxxxxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;(xxxx&xxxx;XX), xxx xxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxx látky ve Vzorku Xxxxxxxxx&xxxx;xxxx&xxxx;Xxxxxxx&xxxx;xx&xxxx;Xxxxx x xxxxxxx,&xxxx;Xxxxxx&xxxx;x/xxxx&xxxx;Xxxxxx&xxxx;xx&xxxx;Xxxxx x Xxxxxx Zakázané xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx Xxxxxxxxxx&xxxx;xxx&xxxx;xxxxxxxxxxxx&xxxx;xxxxx; (x) xxxxxxxxxx xxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;xxxxxxxx se rozhodování x&xxxx;XX&xxxx;x jejich oznamování; (x) xxxxxx, jakým xx&xxxx;Xxxxxxxxx&xxxx;xxxxx x&xxxx;XX; (x) xxxxxx, xxxxx má Sportovec získat TV udělenou xxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x xxxxxxxxx xxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx; (e) xxxxxx, jakým WADA přezkoumává xxxxxxx&xxxx;XX; x (x) xxxxxxxxxx x přísné xxxxxxxxxx, xxxxx xxxx xxxxxxxxxx x průběhu xxxxxxxxx&xxxx;XX.
Xxxxxxx xxxxxxxxx x xxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxx, které jsou xxxxxxxxxx x Kodexu, xxxx xxxxx xxxxxxxx. Xxxxxxx, xxxxx xxxx xxxxxxxxxx v tomto xx jiném Mezinárodním xxxxxxxxx, xxxx xxxxxxxxx.
2.0&xxxx;Xxxxxxxxxx&xxxx;Xxxxxx
Xxxxxxxxxxx články Kodexu 2021 xx xxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky, xxx xx xxxxxx odkazem xx xxxxxxx&xxxx;Xxxxx:
•&xxxx;Xxxxxx 4.4 Kodexu Xxxxxxxxxxxx xxxxxxx&xxxx;("XX")
•&xxxx;Xxxxxx 13.4&xxxx;Xxxxxx&xxxx;Xxxxxxxx xxxxxxxx xx&xxxx;XX
3.0&xxxx;Xxxxxxxx x xxxxxx pojmů
3.1 Pojmy xxxxxxxxxx x Xxxxxx 2021, xxxxx xxxx xxxxxxx x&xxxx;Xxxxxxxxxxxx standardu pro Terapeutické výjimky
ADAMS (ADAMS): Xxxx-Xxxxxx Administration and Xxxxxxxxxx Xxxxxx): xx xxxxxxx&xxxx;XXXX&xxxx;xxx správu databáze xxxx xxxxxx xxxxxxxx xxx zadávání dat, xxxxxx xxxxxxxx, sdílení x xxxxxxx, vytvořený xx pomoc xxxxxxxxxxx xxxxxxx a WADA v jejich xxxxxxxxxxxxxxx xxxxxxxxxx, ve xxxxxxx x legislativní xxxxxxxx xxxxx.
Xxxx&xxxx;(Xxxxx): Xxxxx xxxxxxxxxxxx&xxxx;Xxxxxxx&xxxx;xxxxxxxxxxxxx xxxxxxxx, která xx řízena xxxxxx xxxxxxx (xxxx. xxxxxxxxxx xxx, xxxxxxxxxxx xxxxx Xxxxxxxxxxx xxxxxxxx, Panamerické xxx).
Xxxxxxxxxxxxx organizace (Anti-Doping Organization): WADA nebo Signatář, xxxxx odpovídá xx xxxxxxx pravidel xxx xxxxxxxxxx, implementaci xxxx xxxxxxxxxxx jakékoli xxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxxxxx. Xxxxx xx xxxx. x Xxxxxxxxxxx xxxxxxxxxx výbor, Xxxxxxxxxxx paralympijský xxxxx, xxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx xxxx, xxxxx xxxxxxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxxxx xxxxx&xxxx;Xxxx, Xxxxxxxxxxx federace x&xxxx;Xxxxxxx Antidopingové organizace.
CAS: (The Xxxxx of Arbitration xxx Sport): Xxxxxxxx xxxx xxx sport.
Držení (Possession): Xxxxxxxx, xxxxxxx&xxxx;Xxxxxx, xxxxxxxx xxxxxxx&xxxx;Xxxxxx&xxxx;(xx xxxxxxx xxxx xxxxx xxx xxxxx, xxxxx xx xxxxx xxxxxxx&xxxx;Xxxxx&xxxx;xxxxxxxx xxxxxxxx nebo xxxx xxx xxxxxxxx xxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxxx&xxxx;xxxx xxx xxxxxxxxx, xx xxxxxx se Xxxxxxxx xxxxx nebo Xxxxxxxx xxxxxx xxxxxxxxx), xxxxx x xxx, že xxxx&xxxx;Xxxxx&xxxx;xxxx xxxxxxxx kontrolu xxx Xxxxxxxxx xxxxxx xxxx Xxxxxxxxx xxxxxxx xxxx nad xxxxxxxxx, xx xxxxxx xx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxxx, bude xxxxxxx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx xxxxx na Osoby, xxxxx xxxxxx o xxxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;x xxxx v úmyslu xxxxxxx xxxxxxxx xxx xxxx vykonávat. K xxxxxxxx xxxxxxxxxxxxxxx pravidla, xxxxx xxx pouze x&xxxx;Xxxxxx, xxxxxxx, xxxxxxxx xxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx, xx&xxxx;Xxxxx&xxxx;xxxxxxxx xxxxxxxxxxxxx xxxxxxxx, učiní xxxx&xxxx;Xxxxx&xxxx;xxxxxxxxx xxxxx, xxxxxxx prokáže, xx xxxxx neměla Držení v xxxxxx x výslovně xx&xxxx;Xxxxxx&xxxx;xxx xxxxxxxxxx pro Antidopingovou xxxxxxxxxx&xxxx;xxxxxx. Bez ohledu xx xxxxxx xxxxxxxx x xxxx xxxxxxxx, xxxxx (včetně xxxxxxxxxxxxxx xx xxxxxx xxxxxxx)&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxxxxxxx xxxx&xxxx;Xxxxxx&xxxx;xxx&xxxx;Xxxxx, xxxxx koupi uskuteční.
[Poznámka x Držení: Xxxxx xxxx definice xx xxxxxxxx anabolických steroidů x autě Xxxxxxxxx xxxxxxxxx porušení, pokud Xxxxxxxxx xxxxxxxxx, xx xxxx používal xxxxx xxxx. X xxx xxxxxxx xxxx Xxxxxxxxxxxxx xxxxxxxxxx dokázat, xx x když Xxxxxxxxx xxxxx xxxxxxxx xxxxxxxx xxx xxxxx, věděl x anabolických steroidech x xxx x xxxxxx je xxxxxx. Xxxxxxx v xxxxxxx xxxxxxxxxxxx xxxxxxxx nalezených x domácí xxxxxxxxxx, xx které má xxxxxxx Sportovec i xxxx xxxxxxx/xxxxxxxxx, xxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx, xx Xxxxxxxxx x xxxxxxxxxx x xxxxxxxxxx xxxxx x xx xxx v xxxxxx xx xxxxxx. Xxxxxxx xxxxxx xxxxxx Zakázané xxxxx xxxxxxxxxxx sám x xxxx Držení, x když xxxxxxxxx xxxxxxx nedorazí, xxxxxx xxx xxxxx xxxx xxxx xx poslán xx xxxxxx xxxxx xxxxx.]
Xxxxx&xxxx;(Xxxx): Světový xxxxxxxxxxxxx&xxxx;Xxxxx.
Xxxxxxxxxxx Xxxx&xxxx;(Xxxxxxxxxxxxx Xxxxx):&xxxx;Xxxx&xxxx;xxxx&xxxx;Xxxxxx, kterou xxxx Xxxxxxxxxxx xxxxxxxxxx xxxxx, Mezinárodní paralympijský xxxxx, Xxxxxxxxxxx federace, Organizátor xxxxxxxx Xxxx&xxxx;xxxx jiná xxxxxxxxxxx xxxxxxxxx xxxxxxxxxx, xxxx&xxxx;Xxxx, xx kterou xxxxx x uvedených xxxxxxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxx.
Xxxxxxxxxxx xxxxxxxx&xxxx;(Xxxxxxxxxxxxx Standard): Xxxxxxxx, který xxxxxxx&xxxx;XXXX&xxxx;xx xxxxxxx&xxxx;Xxxxxx. Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;(xx xxxxxx xx xxxxxx xxxxxxxxxxxxxx xxxxxxxxx, xxxxxxx xxxx procedur) xxxx xxxxxxxxxx k závěru, xx procesy, které xxxx uvedeny x&xxxx;Xxxxxxxxxxxx xxxxxxxxx, byly xxxxxxxxxxx xxxxx.&xxxx;Xxxxxxxxxxx standardy zahrnují veškeré Technické xxxxxxxxx&xxxx;xxxxxx xxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx.
Xxxx Xxxxxx&xxxx;(Xxx-xx-Xxxxxxxxxxx): Xxxxxxxx xxxxxx, xxxxx xxxx&xxxx;Xxx Xxxxxxx.
Xxxxxxxxx x výsledky (Results Management): Xxxxxx pokrývající xxxxxx xxxxx xxxx xxxxxxxxxxx xxxxx xxxxxx 5&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx x xxxxxxxx&xxxx;xxxx x xxxxxxx případech (xxxx.&xxxx;Xxxxxxxx xxxxx, Biologický xxx Sportovce, xxxxxxxxxxxx xxxxxxxxx o xxxxx xxxxxx) x xxxx xxxxx xxxx vyrozuměním xxxxxxxx stanovenými x xxxxxx 5&xxxx;Xxxxxxxxxxxxx standardu pro Nakládání x xxxxxxxx, xxxx xxxxxxxx xx po xxxxxxx xxxxxxxx xxxxxxx, xxxxxx xxxxxxxx xxxxxx x první xxxxxxxx xxxx xx xxxxxx xxxxxxxx (xxxxx bylo xxxxxxxx xxxxxx).
Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;(Xxxxxxxx Xxxx-Xxxxxx Xxxxxxxxxxxx): Xxxxxxx xx xxxxxxxx xxxxxx x každé xxxx, xxxxx xxxx xx národní úrovni xxxxxxxx xxxxxxxxx a xxxxxxxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxxxxx pravidla, xxxxxxxxx odběry Vzorků, Xxxxxxxx x xxxxxxxx xxxxx x xxxx xxxxxx. Xxxxxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx příslušným xxxxxxx xx xxxxxx xxxxxx xxxxxx, xxx xxxxxxx xxxxxxxxx xxxx&xxxx;Xxxxxxx xxxxxxxxxx xxxxx&xxxx;xxxx xxxx xxxx xxx xxxxxxxx xxxxxxx.
Xxxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;(Xxxxx Xxxxx Xxxxxxxxxxxxx): Kontinentální xxxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxxx výborů a xxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxx xxxx xxxxxx, xxxxx xxxxxx jako xxxxxx orgány xxx xxxxxxxxxxxxx, regionální xx xxxxx&xxxx;Xxxxxxxxxxx Xxxx.
Xxxxxx&xxxx;(Xxxxxxxxxxxxxx): Xxxxxxxxxxx, xxxxxxxx, dohlížení, xxxxxxxxxx xxxx xxxx xxxxxxxx xx xx&xxxx;Xxxxxxx&xxxx;xxxx&xxxx;Xxxxxx&xxxx;x&xxxx;Xxxxxxx&xxxx;xxxxx&xxxx;Xxxxxx, a xx&xxxx;Xxxxxxxx látky nebo Zakázané xxxxxx. Xxxx xxxxxxxx xxxx xxxxxxxxxx nakládání se Zakázanou xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxxx&xxxx;xxxxxxxxxxx zdravotnickým xxxxxxxxxx v xxxxx xxxx ("bona xxxx") xxx xxxxxxxx x xxxxxxx xxxxxxxxxxxx xxxxx xx s xxxxx xxxxxxxxxxx xxxxxxxxxxx, a xxxx xxxxxxxxxx xxxxxxxxx xx&xxxx;Xxxxxxxxxx xxxxxxx, xxxxx xxxxxx xxxxxxxx xxx&xxxx;Xxxxxxxxx Xxxx Soutěž, xxxxx xx x celkové xxxxxxx neprokáže, xx xxxx&xxxx;Xxxxxxxx látky nejsou určeny xxx xxxxxxxx x xxxxxxx terapeutické xxxxx xxxx xxxx xxxxxx xx xxxxxxx xxxxxxxxxxx xxxxxx.
Xxxxx&xxxx;(Xxxxxxx): Xxxxxxx xxxxxxx, xxxxx xxxxxxxxxxx xxxxxxxx xxxx v xxxxxxx xxxxxxx xxxxxxxxxxx plánovaně x xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx. X xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxx xx&xxxx;Xxxxxx&xxxx;x xxxxxxxx xxxx xxxxxxx, pokud Osoba od Pokusu ustoupí xxxxx, než byl xxxxxxx třetí xxxxxxx, xxxxx xx&xxxx;Xxxxxx&xxxx;xxxxxxxxx.
Xxxxxxxxx xxxxxxxxxxx xxxxx&xxxx;(Xxxxxxx Analytical Xxxxxxx): Xxxxxx x xxxxxxxxxx xxxxxxxxxxxx&xxxx;XXXX&xxxx;xxxx jiné xxxxxxxxxx xxxxxxxxx&xxxx;XXXX, která ve xxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx xxxxxxxxxx xxxxxxxxxxxx xx&xxxx;Xxxxxx&xxxx;xxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx jejích Metabolitů či Markerů, nebo xxxxx xxxxxxxxx xx&xxxx;Xxxxxxx Xxxxxxxx xxxxxx.
Xxx Xxxxxxx&xxxx;(Xx-Xxxxxxxxxxx): Xxxxxx xx 23:59 x den xxxx&xxxx;Xxxxxxx, xxxxx xx má Sportovec zúčastnit, xx konce Soutěže a xxxxxxx xxxxxx&xxxx;Xxxxxx, xxxx xx xx&xxxx;Xxxxxxx&xxxx;xxxxxx.&xxxx;XXXX&xxxx;xxxx pro xxxxxxxxx xxxxx schválit alternativní xxxxxxxx, xxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxx&xxxx;xxxxxxxx xxxxxxxxxxx xxxxxxxxxx, xx xxxx xxxxxxxx xx xxx xxxx sport xxxxxxxx. Po xxxxxxx xxxxxxxxx&xxxx;XXXX&xxxx;xxxxx podle alternativní xxxxxxxx xxxxxxxxxx xxxxxxx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx Akcí v konkrétním xxxxxx.
[Xxxxxxxx x Při Xxxxxxx: Xxx xxxxxxxxx xxxxxxxxxx definici termínu Xxx xxxxxxx xxxxxxxxx xxxxx harmonizaci mezi Xxxxxxxxx xx xxxxx xxxxxxxx, xxxxxxxxx xxxx xxxxxxx xxxxxxxxxx mezi Xxxxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxxx xxxxx pro Xxxxxxxxx Xxx xxxxxxx, xxxxxxxxx xxxxxxxxxx Pozitivním xxxxxxxxxxx nálezům xxxx Xxxxxxxxx během Akce x xxxxxx předcházet xxxxxxx xxxxxxxxxxxxx xxxxx xxxxxxxxx xxxxxx xx Xxxxxxxxxx xxxxx Mimo xxxxxx do xxxxxx Xxxxxxx.]
Xxxxxxx&xxxx;(Xxx): Xxxxx, xxxxxxxx, xxxxxx, xxxxxxx, xxxx xxxxxxxxx jakýmkoli xxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx.
Xxxxxxxxx Xxxxxxxxx&xxxx;(Xxxxxxxxxxxx Xxxxxxx): Fyzická Osoba, xxxxxx xxxxxxxx xxxxxxxxx&xxxx;Xxxxxxx antidopingová xxxxxxxxxx; za xxxxxxxxxxx, xx xxxxxx xxxxxx xxxxxxxxx xxxxxx&xxxx;Xxxxx, která xxxxx pěti let xxxx xxxxxxxxx jakéhokoli xxxxxxxx antidopingových pravidel xxxx&xxxx;Xxxxxxxxxx Mezinárodní xxxxxx&xxxx;(xxx xx xxxxxxxxxx xxxxxx Xxxxxxxxxxx federací v xxxxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x Xxxxxxxxxxx) xxxx&xxxx;Xxxxxxxxxx Xxxxxxx xxxxxx&xxxx;(xxx xxx definuje xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx organizace v xxxxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x Xxxxxxxxxxx), xxxxx zastupovala xxxxxxxxx zemi xx&xxxx;Xxxxxxxxxxx Xxxx&xxxx;x xxxxxxxx xxxxxxxxx xxxx která byla xxxxxxxx xx xxxxxxxxxxx&xxxx;Xxxxxxxx xxx Testování či jiného xxxxxxxx informací o xxxxx xxxxxx vedeného xxxxxxxxx Mezinárodní xxxxxxxx xxxx&xxxx;Xxxxxxx antidopingovou xxxxxxxxxx.
[Xxxxxxxx x Xxxxxxxxxxx Sportovci: Xxxxxx "otevřená kategorie" xx vyloučit xxxxxx, xxxxx je xxxxxxx xx xxxxxxxxx xxxx xxxxxx xxxxxxxxx.]
Xxxxxx&xxxx;(Xxxxxxxxxx Xxxx):&xxxx;Xxxxxx xxxxxxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;x&xxxx;Xxxxxxxx xxxxxx.
Xxxxxx&xxxx;(Xxxxxxxxxxx): Xxxxxxxxxx xxxxx, xxxxx, xxx xxxx xxxxxxxxxx xxxxxxxxx xxxxxx. Xxxxxxxxx xxxxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxx xxxx xx 100 xxxxx x xxxxxxxx. X xxxxxxxxx xxxxxx x xxxxxx xxxxxxxxxxx závodů, xxx xx ceny xxxxxxx xxxxx xxxx x jiných xxxxxxxxxxx, xx xxxxxx xxxx&xxxx;Xxxxxxx&xxxx;x&xxxx;Xxxx&xxxx;xxxxxx xxxxx pravidel příslušné Xxxxxxxxxxx federace.
Sportovec (Athlete): Jakákoli Osoba, xxxxx soutěží xx xxxxxx xx xxxxxxxxxxx xxxxxx (xxxxxx definují xxxxxxxxxx Xxxxxxxxxxx xxxxxxxx) xxxx xx xxxxxxx xxxxxx (xxxxxx definují xxxxxxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx organizace). Antidopingová xxxxxxxxxx&xxxx;xx xxxx xxxx xxxxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx na Sportovce, xxxxx xxxx Xxxxxxxxxx xxxxxxxxxxx úrovně xxx&xxxx;Xxxxxxxxxx xxxxxxx xxxxxx, x xxx na xxxx xxxxxxxx xxxxxxxx "Sportovce". Xxx&xxxx;Xxxxxxxxx, xxxxx xxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx xxxxxxx xxxxxx, může Antidopingová xxxxxxxxxx&xxxx;xxxxxxxx xxxxxxx Xxxxxxxxx&xxxx;xxxx neprovádět xxxxx&xxxx;Xxxxxxxxx; xxxxxxxxxxxx&xxxx;Xxxxxx&xxxx;xxx xxxxx xxxxx&xxxx;Xxxxxxxxxx xxxxx; xxxxxxxxx xxxxxxx informace x xxxxx xxxxxx nebo xxxxxxxxxxx xxxxx; xxxxxxxxxxx xxxxxx&xxxx;XX. Xxxxx xxxxx xxxxx podle xxxxxx 2.1, 2.3 nebo 2.5 k porušení xxxxxxxxxxxxxxx pravidla Sportovcem, u xxxxx xx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx, xx xxxxxxx svou xxxxxxxx testovat, x xxxxx xxxxxxx pod xxxxxxxxxxx nebo xxxxxxx xxxxxx, xxx xxxx xxx xxxxxxxxx&xxxx;Xxxxxxxx&xxxx;xxxxxxxxx x&xxxx;Xxxxxx. Xxx účely článků 2.8 a 2.9 x xxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxx a Vzdělávání, každá Osoba, xxxxx xxxxxxx či xx xxxxxxx&xxxx;Xxxxxxx&xxxx;xx sportu, xxxxx spadá xx xxxxxxxxx xxxxxxxxxxx&xxxx;Xxxxxxxxx, vlády xxxx xxxx xxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxx&xxxx;Xxxxx, xx považována xx&xxxx;Xxxxxxxxx.
[Xxxxxxxx xx Sportovci: Xxxxxxxxxxx, xxxxx se xxxxxxx xxxxxx, xxxxx xxxxxx xx jedné x xxxx kategorií: 1)&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxxx, 2) Xxxxxxxxx xxxxxxx úrovně, 3) xxxxxxxxxxx, kteří xxxxxx Sportovci xxxxxxxxxxx xxxx xxxxxxx úrovně, xxx nad nimiž xx xxxxxxxx xxxxxxxxx xxxxxxxx Mezinárodní xxxxxxxx xxxx Národní antidopingová xxxxxxxxxx, 4) Rekreační Xxxxxxxxx x 5) xxxxxxxxxxx, nad nimiž xxxxx Xxxxxxxxxxx xxxxxxxx xxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx xxx xx nerozhodla xxxxxxxx vykonávat. Xx xxxxxxx Sportovce xxxxxxxxxxx x xxxxxxx úrovně xx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx Xxxxxx x xxxxxxxx definicemi xxxxxx xxxxxxxxxxx x národní xxxxxx, xxxxx budou xxxxxxxxx x xxxxxxxxxxxxxxx xxxxxxxxxx Xxxxxxxxxxxxx xxxxxxxx x Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx.]
Xxxxxxxxx mezinárodní xxxxxx&xxxx;(Xxxxxxxxxxxxx-Xxxxx Xxxxxxx):&xxxx;Xxxxxxxxx, xxxxx se xxxxxxx sportu na xxxxxxxxxxx xxxxxx, jak xx xxxxxxxxxx každou Xxxxxxxxxxx xxxxxxxx xx xxxxx s Mezinárodním xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxx.
[Xxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx xxxxxx: V souladu x Xxxxxxxxxxxx xxxxxxxxxx xxx Xxxxxxxxx x Xxxxxxxxxxx xxxx Mezinárodní xxxxxxxx xxxxxxxx stanovit xxxxxxxx, xxxxx xxxxxxx xx xxxxxxxxxxx Xxxxxxxxx xxxx Xxxxxxxxx xxxxxxxxxxx xxxxxx, xxxx. xxxxx xxxxxxxxx, účastí na xxxxxxxxxxx Mezinárodních akcích, xxxxx typu xxxxxxx xxx. Musí xxxx xxxx kritéria xxxxxxxxx xxxxxx x stručnou xxxxxx, xxx Xxxxxxxxx xxxxx rychle x xxxxxx xxxxxxx, kdy xxxxx xxxxxxxxxxxxx xxxx Xxxxxxxxx xxxxxxxxxxx xxxxxx. Xxxxx například kritéria xxxxxxxx xxxxx na xxxxxxxx Mezinárodních xxxxxx, xxxx Mezinárodní xxxxxxxx Xxxxxx xxxxxx Mezinárodních xxxx xxxxxxxxx.]
Xxxxxxxxx xxxxxxx xxxxxx&xxxx;(Xxxxxxxx-Xxxxx Athlete): Sportovci, kteří xx účastní sportu xx xxxxxxx xxxxxx, xxx xx xxxxxxxxxx xxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxxx x&xxxx;Xxxxxxxxxxxx xxxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxx.
Xxxxxxxxxxxx xxxxxxx&xxxx;("XX") (Xxxxxxxxxxx Xxx Xxxxxxxxx):&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;xx zdravotním xxxxxxxxxxx Xxxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx, xxx pouze xxxxx, jsou-li xxxxxxx xxxxxxxx xxxxxxxxx x xxxxxx 4.4 x x&xxxx;Xxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky.
Testování (Testing): Xxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxxxxx&xxxx;xxxxxxxxxx xxxxxxxxx testu, xxxxx&xxxx;Xxxxxx, xxxxxxxxx xx&xxxx;Xxxxxxx&xxxx;x xxxxxxxxx&xxxx;Xxxxxx&xxxx;xx xxxxxxxxxx.
Xxxxxxxxxx&xxxx;(Xxxxxxxxx): Xxxxxxxxxx xxxxxx, xxxxx xxxxxx je xxxxxxx xxxxxxx x xxxxxxxx xxxxxx, které xxxxxxxx x xxxxxx xxxxxxxxxxx xxxxx a xxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxx dopingu.
Vzorek (Sample xx Xxxxxxxx): Xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxxxxx xx xxxxxx&xxxx;Xxxxxxxxx xxxxxxxx.
[Xxxxxxxx xx Xxxxxx: Xxxxx xx xxxxx, že odběr Xxxxxx xxxx xxxxxxxx xxxxxxxx určitých xxxxxxxxxxxx xxxx xxxxxxxxxx xxxxxx. Xxxx stanoveno, že xxx takové tvrzení xxxxxxxxxx xxxxx xxxxxx.]
XXXX&xxxx;(Xxx Xxxxx Xxxx-Xxxxxx Xxxxxx): Xxxxxxx xxxxxxxxxxxxx agentura.
Zakázaná xxxxx&xxxx;(Xxxxxxxxxx Xxxxxxxxx): Xxxxxxxx xxxxx nebo skupina xxxxx xxxxxxx v Seznamu.
Zakázaná xxxxxx&xxxx;(Xxxxxxxxxx Xxxxxx): Jakákoli xxxxxx uvedená v Seznamu.
3.2 Definované xxxxx x&xxxx;Xxxxxxxxxxxxx standardu pro xxxxxxx xxxxxxxx a xxxxxxxx údajů
Osobní xxxxx:&xxxx;Xxxxx, xxxx xxxx xxxxxx&xxxx;Xxxxxxxxx xxxxxxxx xxxxx, xxxxxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx jiné Osoby, xxxxxxx xxxxxxxxx byla xxxxxxxxx xxxx je možné xx xxxxxxxx, x xxxxxxx xxxxx xxxx&xxxx;Xxxxxxxxxxxx&xxxx;xxxxxxxx x xxxxxxxxxxx x&xxxx;xxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx.
[Xxxxxxxx x&xxxx;Xxxxxxx xxxxxx:&xxxx;Xxxxxx se, xx&xxxx;Xxxxxx xxxxx&xxxx;xxxxxxxx mimo xxxx xxxxx xxxxxxxx xx jména Xxxxxxxxx, xxxx xxxxxxxx, xxxxxxxxxxx xxxxx x sportovních xxxxxxxx, xxxxx xxxxxx, xxxxxxxxxxx XX (xxxx-xx xxxxxx), xxxxxxxx xxxxxxxxxxxxxxx xxxxx x xxxxxxxx xxxxxxxx xxxxxx (xxxxxx xxxxxxxxxxxxxxx xxxxxx, xxxxxxxx x sankcí). Osobní xxxxx&xxxx;xxxx xxxxxxxx xxxxxx x xxxxxxxxx informace xxxxxxxx xx jiných Xxxx, xxxx xxxxxxxxx zdravotnických xxxxxxxxx xxxxxxxxxx xxxx xxxxxx Xxxx, xxxxx xxxxxxx xx Xxxxxxxxxx, xxxxxxxx xxx nebo xx pomáhají x xxxxx Xxxxxxxxxxxxx xxxxxxxx. Xxxxxx xxxxxxxxx xxxx xxxxx považovány za Osobní xxxxx&xxxx;x xxxx xxxxx Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xx xxxxx dobu xxxxxx&xxxx;Xxxxxxxxxx, xxx xxxxxx xx to, xxx xx xxxxxxxxx jednotlivec xxxxx xxxxxxx xx xxxxxxxxxxxxxx sportu.]
Zpracování (a tvary xxxxx&xxxx;Xxxxxxxxxx,&xxxx;Xxxxxxxxxxxx&xxxx;xxxx.): Shromažďování, xxxxxxx, xxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, přenos, xxxxx, xxxxxx xxxx xxxx xxxxxxxxx&xxxx;Xxxxxxxx údajů.
3.3 Definované xxxxx, xxxxx xxxx xxxxxxxxxx xxx&xxxx;Xxxxxxxxxxx standard pro Terapeutické xxxxxxx
Xxxxxx xxx terapeutické xxxxxxx ("XXX")&xxxx;(Xxxxxxxxxxx Xxx Exemption Xxxxxxxxx xx "TUEC"): Orgán xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxxxx xxxxxxxxxx xxxxxxx x&xxxx;XX.
XXX XXXX&xxxx;(XXXX XXXX): Orgán xxxxxxxxxx&xxxx;XXXX&xxxx;xx účelem xxxxxxxxxxxxx xxxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x&xxxx;XX.
Xxxxxxxxxxxx&xxxx;(Xxxxxxxxxxx): Xxxxxxxxxx se x xxxxx xxxxxxxxxxx xxxxx xxxxxxxxx xxxxxxxxxx nebo xxxxxxxx; xxxx xxxxxxxxxxx xx xxxxxxxxxxxx xxxxxxxxx.
3.4&xxxx;Xxxxxx xxxxx
3.4.1&xxxx;Xxxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxx xxxxxxxxxx v xxxxxxxxxx a xxxxxxxxxxxxx. X xxxxxxx xxxxxxxxxx xxxxxxx xxxx xxxxxxxxx x xxxxxxxxxxxx xxxxx xxxxx xxxxxxxx xxxxx.
3.4.2&xxxx;Xxxxxx xxxx&xxxx;Xxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxx standard pro Terapeutické xxxxxxx&xxxx;xxxxxxxxxx x xxxxxxx na xxxxxx xxxxxxxxxxxxxxx, lidská xxxxx x xxxxx xxxxxxxxx právní zásady. X x tomto xxxxxx bude xxxx xxxxxxxx x aplikován.
3.4.3 Poznámky xxxxxxxxxxx xxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx výjimky jsou xxxxxxx x jejich xxxxxxxxxxxx.
3.4.4&xxxx;Xxxxx xxxx stanoveno jinak, xxxxxx xx xxxxx x xxxxxx xxxx xxxxxx xx xxxxx x xxxxxx&xxxx;Xxxxxxxxxxxxx standardu pro Terapeutické xxxxxxx.
3.4.5&xxxx;Xxxxxx "xxx" xxxxxxx x&xxxx;Xxxxxxxxxxxx standardu pro Terapeutické xxxxxxx&xxxx;xxxxxxxxxx xxx, pokud xxxx xxxxxxx xxxxx.
3.4.6&xxxx;Xxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx&xxxx;xxxx xxxxxx xxxxxxx xxxxxxxx xxxx zbytek Mezinárodního xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxxxxx xxxxxxx.
XXXXX XXXX: XXXXXXXXX X POSTUP XXX XXXXXXXXX TV
4.0 Udělování TV
Sportovec, xxxxx x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx xxxxxxxxx xxxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx, xxxx xxxx&xxxx;Xxxxxxxx&xxxx;xxxx&xxxx;Xxxxxxx xxxxxxxx xxxxx nebo xxxxxx xxxxxxx x&xxxx;XX, xxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx o TV se xxxxxxx xxxxxxxxx xxxxx xxxxxx 4.1. V xxxx xxxxxxxxx musí xxx xxxxxxx xxxxxxxx xxxxxx 4.2.
[Xxxxxxxx k xxxxxx 4.0: Xxxxx xxxxxx xxxxxxx, kdy xx Sportovec xxxxxxx x xxxxx xxxx xx v držení Xxxxxxxxx látku xxxx Xxxxxxxxx xxxxxx předtím, xxx se xx xxxx začnou xxxxxxxxx xxxxxxxxxxxxx xxxxxxxx. V xxxxxxx xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx užívání/držení XX a xxxx xxxxxxxxxx&xxxx;XX&xxxx;x budoucí xxxxxxxxx.]
4.1&xxxx;Xx xxxxxxx&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x&xxxx;XX&xxxx;xxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xxxx, xx dotyčnou xxxxx nebo xxxxxx&xxxx;xxxx&xxxx;xxxx&xxxx;xxx x xxxxxx.
Xxxxxxxxx&xxxx;xxxx x&xxxx;XX&xxxx;xxxxxxx xx zpětnou platností (xxxx xxxx xxxxx xxxxxxxx podmínky xxxxxx 4.2), xxxxx xxxxx xxxxxxx x xxxxxxxxxxxxx xxxxxxx:
x)&xxxx;Xxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxxx xxxxx xxxxxxxx xxxxxxxxxxx xxxxx;
x)&xxxx;Xxxxx xxxxxxxxxx okolnostem xxxxx xxxxxxxx času xx xxxxxxxxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxx xxxxxx x&xxxx;XX&xxxx;(xxxx KTV xxxxxxx xxxxxx) xxxx xxxxxxx&xxxx;Xxxxxx;
x)&xxxx;X xxxxxx xxxxxxxxxxxxxxx určitých xxxxxx xxxx xxxxxxxxx xx xxxxxxx xxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx Sportovce nepovolila xxx xxxxxxxxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x xxxxxxxxxxx&xxxx;XX&xxxx;(xxx xxxxxxxx x xxxxxx 5.1);
d) Pokud xx&xxxx;Xxxxxxxxxxxxx organizace rozhodne xxxxxxx&xxxx;Xxxxxx&xxxx;xx&xxxx;Xxxxxxxxx, xxxxx xxxx&xxxx;Xxxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxxx národní úrovně, x xxxxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx xxxxxxx&xxxx;Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx metodu, Antidopingová xxxxxxxxxx&xxxx;xxxx xxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x&xxxx;XX&xxxx;xx zpětnou xxxxxxxxx; xxxx
x)&xxxx;Xxxxxxxxx Xxxxxx Xxxx Xxxxxx&xxxx;x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxxx xxxxx, xxxxx xx xxxxxxxx xxxxx&xxxx;Xxx Soutěži.
[Poznámka x xxxxxx 4.1: Xxxxxxx xxxxx x xxxxxxx xxx TV xx xxxxxxx xxxxxxxxx xxxxxxxxx, xx xxxx XX xxxxxxxx xxxxxxx; xxxxxxx xx, xx žádost Xxxxxxxxx může xxx xxxxxxxxxxx xxxxx xxxxxx 4.2, xxx xx xxxxxxxx, xxx xxxx xxxxxxx xxxxxxxxx xxxxxxxx XX.]
[Xxxxxxxx x xxxxxx 4.1 x), x) x x): X xxxxxxx, kdy xx xx xxxxxx Xxxxxx xxxxx xxxxxx x XX xx zpětnou xxxxxxxxx, xx Xxxxxxxxxx xxxxxxx xxxxxxxxxx, xxx xx nechali xxxxxxxxx xxxxxxxxx xxxxxxxxxxx x xxxx xxxxxxxxxx prokázat xxxxxxx xxxxxxxx pro XX xxxxxxxxxxx v xxxxxx 4.2.]
[Poznámka x xxxxxx 4.1 x): Xxxxx je xxxxx xxxxxxx, xxx Xxxxxxxxx x&xxxx;Xxxxxxxxxxxxxx&xxxx;xxxxxx Xxxxxxx Xxxx Xxxxxx xxxxx, xxxxx xx xxxxxxxx pouze Xxx Xxxxxxx, xxx xxxxxxxx xxxxxx, xx xxxxx xxxxxxx Xxx Xxxxxxx x xxxxxx xxxx.
X xxxxxxxx xxxxxxxxx xxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxx x XX xx xxxxxxx xxxxxxxxx (xxxxx Xxxxxxxxx nepožádal x XX předem). Toto xxxx xxxxxxx x xx, aby Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx předem xxxxxxxxx žádosti o XX, které xxxxxx xxx xxxxx.]
4.2&xxxx;Xxxxxxxxx&xxxx;xxxx xxx xxxxxxx&xxxx;XX, pokud (x xxxxx pokud) xxxx xxxxxxxx, xxx uvážení xxxxxxxxxxxxxxxx, xx je xxxxxxx každá x xxxxxxxxxxxxx xxxxxxxx:
x)&xxxx;Xxxx&xxxx;Xxxxxxxx látka nebo Zakázaná xxxxxx&xxxx;xx xxxxx x xxxxx diagnostikovaných zdravotních xxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxxx xxxxxx.
[Xxxxxxxx k xxxxxx 4.2 x): Xxxxxxx Zakázané xxxxx xxxx Xxxxxxxx metody xxxx xxx xxxxx xxxxxxxx nezbytného xxxxxxxxxxxxxx xxxxxxxxx než xxxxxxxx xxxxxx.]
x)&xxxx;Xxxxxxxxxxxx&xxxx;Xxxxxxx Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;x xxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxx xxxxx jiné xxxxxxx výkonu Sportovce, xxx xxxx xxx xxxxxxxx xxxxxxxxxx do xxxxxxxxxx xxxxxxxxxxx xxxxx xxxxxxxx xx xxxxx xxxxxxxxxxx xxxxxx.
[Xxxxxxxx x xxxxxx 4.2 x): Xxxxxxxx xxxxxxxxx xxxx Xxxxxxxxx xxxx třeba určit xxxxxxxxxxxx. Normální xxxxxxxxx xxxx xxx xxxxxxxxxxx Xxxxxxxxx je jeho xxxxxxxxx stav, ale xxx xxxxxxxxxxx potížích, xxxxx xxxxxx Xxxxxxxxx xxxx x TV.]
c) Zakázaná xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xx xxxxxxxxxxx xxxxxx xxxxxxxxxxx potíží x xxxxxxxxxx žádná xxxxxxxxxx xxxxxxxx&xxxx;Xxxxxxxxxxxx&xxxx;xxxxxxxxxxx.
[Xxxxxxxx k xxxxxx 4.2 x): Xxxxx xxxx xxxxxxxxx, xxxx xxxx zvolená xxxxx nejvhodnější, xxxx. xx základě zkušeností, xxxxxxx xxxxxxxxxx účinků xxxx jiných xxxxxxxxxx xxxxxxxxxx, včetně, xx-xx xx xxxxxxxxxx, xxxxxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx x xxxxxxxx xxxxxxxx x xxxxx. Dále xxxx vždy xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxxx xxxx použitím Zakázané xxxxx xxxx Xxxxxxxx xxxxxx.]
x)&xxxx;Xxxxxxx xxxxxxx&xxxx;Xxxxxxxx látky nebo Zakázané xxxxxx&xxxx;xxxxxx xxx následkem, xxxxx xxxx xxxxxx, xxxxxxxxxx&xxxx;Xxxxxxx&xxxx;(xxx&xxxx;XX) xxxxx xxxx xxxxxx, xxxxx byla x xxxx xxxxxxxx&xxxx;Xxxxxxx&xxxx;xxxxxxxx.
[Xxxxxxxx x článku 4.2: Xxxxxxxxx WADA x xxxxxx "Xxxxxxxx xxxxxxxxx xxx xxxxxxxxxxx x XX", umístěné na xxxxxxxx stránkách XXXX, xx xx měly xxxxxxxx, xxx xx xxxxxxxxx aplikování těchto xxxxxxxx, xxxxx xxx x xxxxxxxxx zdravotní xxxxxx.
Xxxxxxx XX je xxxxxxxx xxxxx xx xxxxxxx xxxxxxxx stanovených x článku 4.2. Xxxxxxxxxxxx, zda xx Xxxxxxxx xxxxx nebo Xxxxxxxx metoda xxxxxxxx xxxxxxxxxxxx xxxx nejbezpečnější, xxxx zda xx xxxx Použití xxxxxxx xx všech jurisdikcích.
Pokud XXX Xxxxxxxxxxx xxxxxxxx xxxx Organizátora xxxxxxxx Xxxx xxxxxxxxx, xxx xxxxx nebo neuznat XX schválenou xxxxx Xxxxxxxxxxxxxx xxxxxxxxxx (xxx xxxxxx 7), x xxxxx XXXX xxxxxxxxxxx xxxxxxxxxx x xxxxxxx (xxxx xxxxxxxxx) XX (xxx článek 8), xxxxxxxx xxxx xxxxxx xxxx x případě xxxxxxxxxx xxxxxxx o Xxxxxxxxxxxxx xxxxxxx Xxxxxx xxx XX xxxxx xxxxxx 6, xx., xxxxxxxx Xxxxxxxxx při xxxxxxx xxxxxxxxxxxxxxxx, že xx xxxxxxx xxxxx x xxxxxxxx xxxxxx 4.2?]
4.3&xxxx;Xx xxxxxxxxxxx okolností x xxx xxxxxx xx xxxxxxxx xxxx xxxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx standardu pro Terapeutické xxxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx x xxxxxxxxx&xxxx;Xxxxxxxxxxxxxx&xxxx;Xxxxxxx Xxxxxxxx látky nebo Zakázané xxxxxx&xxxx;xx xxxxxxx xxxxxxxxx, xxxxx xx xxxx xxxxxxx, xxxxx xx x xxxxxxx xx xxxx Xxxxxx xxxx xxxxxx xxxxxxxxxxxxx&xxxx;XX&xxxx;xx xxxxxxx platností xxxxxxxx. X&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;x&xxxx;Xxxxxxxxx xxxxxxx xxxxxx xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx xxxxxxx x&xxxx;XX&xxxx;xx zpětnou xxxxxxxxx xxxxx xxxxxx xxxxxx xxxxx x xxxxxxxxxx xxxxxxxxx&xxxx;XXXX&xxxx;(x&xxxx;XXXX&xxxx;xxxx podle svého xxxxxxxxxxx xxxxxxx x xxxxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxx, nebo xxx xxxxxxxxx).
X&xxxx;Xxxxxxxxx, xxxxx xxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxxx xxxxxx, může xxxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace vyhovět xxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx xxxxx tohoto xxxxxx xxx xxxxxxxxx konzultace x&xxxx;XXXX;&xxxx;XXXX&xxxx;xxxx může kdykoli xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace udělit TV se xxxxxxx xxxxxxxxx xxxxx xxxxxx xxxxxx xxxxxxxxxx a xxxx xxxxx xxxxx xxxxxxxxxxx uvážení x xxxxxxxxxxx xxxxxxxxx, xxxx xxx xxxxxx. Proti xxxxxxxxxx xxxxxxxxxx učiněnému WADA a/nebo Antidopingovou xxxxxxxxxx&xxxx;xxxxx tohoto xxxxxx xxxxx xxxxxx xxxxxxx xxxxx řízení o xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxx xxxxxxxxxxxxxxx xxxxxxxx, xxx xxxxx.
Xxxxxxx rozhodnutí Antidopingové xxxxxxxxxx&xxxx;xxxxx xxxxxx článku 4.3, xx xx xxxxxxxxxx, xxxx zamítnutí TV, xxxx xxx nahlášena xxxxxxxxxxxxxxx&xxxx;XXXXX&xxxx;x xxxxxxx s xxxxxxx 5.5.
[Xxxxxxxx x xxxxxx 4.3: Aby xx předešlo xxxxxxxxxxxx, xxxx xxx xxxxx xxxxxx 4.3 xxxxxxx xxxxxxxxx xx xxxxxxx xxxxxxxxx, x xxxx xxxxxx xxxxxxx xxxxxxxx x xxxxxx 4.2 (xxxxxx splnění těchto xxxxxxxx xxxx xxx xxxxxxxxxx xxxxxxxxxx). Xxxx xxxxx relevantní xxxxxxx xxxxx xxxxxx xxxx. xxxxxx, proč Sportovec xxxxxxxxx o XX xxxxxx; zkušenosti Sportovce; xxxxxxxx, xxxxx Xxxxxxxxx xxxxxxx xxxxxx; xxx Xxxxxxxxx deklaroval Xxxxxxx xxxxx nebo xxxxxx xx xxxxxxxx Xxxxxxxxx xxxxxxxx; x xxxxxxx xxxxxxxx TV Sportovce. Xxx svém xxxxxxxxxxx xx může XXXX xxxxx xxxxx xxxxxxx xxxxxxx xx xxxxxx (xxxxx)&xxxx;XXX XXXX.]
5.0&xxxx;Xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxx xx&xxxx;XX
5.1&xxxx;Xxxxxx 4.4 Kodexu specifikuje a) xxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxxxxxx xxxxxxxxxx x&xxxx;XX; b) xxx xx xxxx xxx xxxx rozhodnutí x&xxxx;XX&xxxx;xxxxxxxx x respektována xxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxxxx; a x) xxx xxxxx xxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxxxxxxxx x/xxxx jak se xxxxx xxx xxx xxxxxxx.
[Xxxxxxxx x xxxx 5.1: Xxx příloha 1 - postupový xxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxx 4.4 Xxxxxx.
X xxxxxxxxx, xxx xxxxxxxxx x priority xxxxxxx politiky xxxxx Xxxxxxx antidopingovou xxxxxxxxxx x xxxx, xxx xxxxxxxxxxxxxxx xxxxxx xxxxxx xxxx disciplíny před xxxxxx xxx plánování Xxxxxxxxx (jak xx xxxxxxxxxxx xxx xxxxxx 4.4.1 Xxxxxxxxxxxxx xxxxxxxxx xxx Xxxxxxxxx x Xxxxxxxxxxx), Národní xxxxxxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxxxxx xxxxxxx x XX Xxxxxxxxx x xxxxxxxxx xxxxx xx xxxxx neprioritních xxxxxx xxxx xxxxxxxxx, xxx x tom xxxxxxx xxxx xxxxxxx xxxxxxx xxxxxxxx Sportovci, xxxxxxx je xxxxxxxx xxxxxxx Xxxxxx, xxxxx x TV xx xxxxxxx xxxxxxxxx. Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx by xxxx, xx xxxxxxxxx Xxxxxxxxx, xxxxxxx xx xx xxxx, xxxxx xxxxxx xxxxxxxxxx xx xxxxx webových xxxxxxxxx.
Xxxxxx 4.4.2 Xxxxxx xxxxxxxxxxx xxxxxxxxx Xxxxxxx antidopingové xxxxxxxxxx rozhodovat x XX v xxxxxxx Xxxxxxxxx, xxxxx xxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxxx. X případě sporu xxxxxxx toho, xxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xx měla xxxxxxxxx xxxxxx x XX Xxxxxxxxx, xxxx xxxx Xxxxxxxxxx mezinárodní xxxxxx, xxxxxxxx XXXX. Xxxxxxxxxx XXXX xxxx xxxxxxx x nelze xx xxxxx xxxx xxxxxxx.]
5.2&xxxx;Xxx xxxxxxxxx pochybností, xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx&xxxx;Xxxxxxxxx XX, xxxx&xxxx;XX&xxxx;xx xxxxxx xx xxxxxxx úrovni x xxxxxxxxx xxxxxxx a xxxxxx xxx formálně xxxxxx jinými Národními xxxxxxxxxxxxxxx xxxxxxxxxxxx&xxxx;xxxxx xxxxxx 7.0 (xxxx. pokud xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx&xxxx;XX&xxxx;xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x ten xxxx xxxxxxx nebo xxxxxxx x zemi xxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, xxxx tato TV platná, xxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx).
5.3&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Mezinárodní xxxxxxxx xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx akcí musí xxxxxxxxx&xxxx;XXX,&xxxx;xxxxx xxxxxxxx, xxx xxxxxxx x xxxxxxx xxxx xxxxxx&xxxx;XX&xxxx;xxxxxxx xxxxxxxx xxxx v článku 4.2.
[Xxxxxxxx k xxxxxx 5.3: Xxx xxxxxxxxx xxxxxxxxxxx, xxxxxxx xxxxxxxx xxxxxxxxxxx x xxxxxxxx 4.1 a 4.3 xxxx xxxxx xxxxxxxxx Xxxxxxxxxxxxx organizace xx xxxxxxxxxx xx xxxxxx (xxxxx) KTV.
I xxxx xx Xxxxxxxxxxx xxxxxxxx xxxx xxxx xxxxxx, xx bude xxxxxxx xxx xxxxx xxxxxxx XX automaticky, xxxx xxxxxxxxx mechanismus, xxxxxx Xxxxxxxxx xxxxxxxxx xx Xxxx bude xxxx xxxxxx xxxxx XX, xxxxxxxx to xxxx xxxxxxx. Xx xx xxxxxx Organizátorovi xxxxxxxxxx xxxx, zda si xxxxxx pro xxxxx xxxx xxxx xxxxxxx XXX, xxxx xxx xxxxxx xxxxx xxxx xx xxxxxxxxx xxxxxxxx xx třetí xxxxx. Xxxxx xx x xxxxxx xxxxxxx mělo xxx xxxxxxxx, xxx Xxxxxxxxx účastnící xx xxxxxx Xxxx xxxx xxxxxxx získat XX xxxxxx x x xxxxx xxxxxxxxx xxxx xxx, xxx xxxxxx xxxxxxxx.]
x)&xxxx;XXX&xxxx;xx se xxxx xxxxxxx xxxxxxx xx xxx (3) xxxxxx xx xxxxxxxxxxx x xxxx x xxxxxx&xxxx;Xxxxxxxxx&xxxx;x xxxxxxxx znalostí xxxxxxxx x xxxxxxxxx zátěžové xxxxxxxx. X xxxxxxxxx, xxx je xxxxxxxxxx xxxxxxxx odbornost (xxxx. x&xxxx;Xxxxxxxxx&xxxx;x postižením, kde xx xxxxx xxxx xxxxxx xxxx postižení Sportovce), xx alespoň xxxxx (1) z xxxxx&xxxx;XXX&xxxx;xxx xxx xxxxxx xxxxxxxxxx. Xxxxx (1) x xxxxx, který xx xxxxx, by xxx xxxxxxx xxxx xxxxxxxx&xxxx;XXX.
x)&xxxx;Xxx xxxx xxxxxxxxx nestrannost xxxxxxxxxx, xxxx xxxxxxx xxxxxxx&xxxx;XXX&xxxx;xxxxxxxx xxxxxxxxxx x xxxxxxxxx střetu xxxxx x x xxxxxxxxx xxxxxxxxxx údajů (vzor xxxxxxxxxx xx k xxxxxxxxx xx xxxxxxxx xxxxxxxxx&xxxx;XXXX).
5.4&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxxx ustanovit xxxxx postup, xxx xxxxx x xxx&xxxx;XXX&xxxx;x&xxxx;XX, xxxxx xx x xxxxxxx x xxxxxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx. Xxxx xxxx zveřejnit podrobnosti xxxxxx xxxxxxx tím, xx (minimálně) xxxxxx xxxx xxxxxxxxx na xxxxx xxxxxxxxxx místě xx xxxxx xxxxxxxx xxxxxxxxx.
5.5&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Xxxxxxxxxxx federace xxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx akcí musí xxxxxxxxxx xxxxxxx xxxxxxxx (x xxxxxxxxxx xxxx xxxxxxxxxxxxx) x xxxxx rozhodnutích xxxxx&xxxx;XXX&xxxx;x xxxxxxx či xxxxxxxxx&xxxx;XX&xxxx;x x xxxxx xxxxxxxxxxxx xxxxxx xx xxxxxxxxx xxxxxxx 7X xxxxxx Xxxxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx XXXXX, x xx co xxxxxxxx, x každém xxxxxxx xx dvaceti jedna (21) dnů xx xxxxxxx rozhodnutí. Rozhodnutí x xxxxxxxxx&xxxx;XX&xxxx;xxxx obsahovat xxxxxxxxxx xxxxxx xxx xxxxxxxxx. Xxxxxxx udělených TV musí xxxxxxxx xxxxxxxxx obsahovat (x angličtině xxxx xxxxxxxxxxxxx):
x)&xxxx;xxx byl Sportovec oprávněn zažádat x&xxxx;XX&xxxx;xx zpětnou platností xxxxx xxxxxx 4.1 x xxxxxxxxxx xxxxxx xxxx, xxxx xxx xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx zažádat x&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx, zda xx byla xxxxxxx xxxxx xxxxxx 4.3 x vysvětlení xxxxxx xxxx;
x)&xxxx;xxxxxxxxxx látku xxxx xxxxxx, dávkování, frekvenci, xxxxxxxx xxxxxx&xxxx;Xxxxxxxx, xxxx xxxxxx&xxxx;XX&xxxx;(x dobu předepsané xxxxx, pokud xx xxxx) x všechny xxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx x&xxxx;XX; x
x)&xxxx;xxxxxxxx žádosti x&xxxx;XX&xxxx;(xxxxx xxxx xxxxxxx xxxxxxxxxxxx x ADAMS) a xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xxxxxxxxxxx, že podmínky xxxxxx 4.2, pokud xxx x xxxx&xxxx;XX, xxxx xxxxxxx (xxxx xxxxxxxxx budou x xxxxxxxxx xxxxx&xxxx;XXXX,&xxxx;Xxxxxxx antidopingové xxxxxxxxxx Xxxxxxxxx, Mezinárodní xxxxxxxx x&xxxx;Xxxxxxxxxxxxxx významných xxxx, xxxx pořádá Akci, xxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxxxx).
[Xxxxxxxx x xxxxxx 5.5: Xxxxx je xxxxxxxx xxxxxxxx xxxxxxx o XX, xxxx xxx Xxxxxxxxxxxxxxx organizacemi xxxxxxxx xx xxxxxx jazyků, xxx na xxxxxxxxx xxxx xxxxxx xxxxxxx xxxxxxxx xxxx francouzský xxxx x xxxx xxx xxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxxxxx xxxxxx.
Xxxx xxx poskytnuty xxxxx xxxxxxxx záznamy, xxxxxx diagnostických testů, xxxxxxxxxxxxx xxxxxxxx a xxxxxx, xxx nemusí xxx xxxxxxxxx xx xxxxxxxxxx xxxx francouzštiny. Xx systému ADAMS xxxx xxxx xxx xxxxxx xxxxxxxxx xxxxxxx xxxxx klíčových xxxxxxxxx (xxxxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx) s dostatečnými xxxxxxxxxxx, aby bylo xxxxx xxxxx xxxxxxxx xxxxxxxx. Xxxxxxx xx xxxxxxxxxx, xxx xxxxxx xxxxxxx xxxxxxxxx xxxxx xxxx xxxx osoba x xxxxxxxxxxxxxx xxxxxxxxxx xxxxxxxxx, aby bylo xxxxx lékařské informace xxxxxxx pochopit a xxxxxxx. Xxxxxxxxxxx/xxxxxxxx xxxxxxxx xxxx požadovat xxxxxxxxx Xxxxxxxxxxxxx organizace nebo XXXX, xx vyžádání.]
5.6 Když Národní xxxxxxxxxxxxx organizace udělí Sportovci XX, xxxx xxx xxxxxxx xxxxxxxxx, že a) xx&xxxx;XX&xxxx;xxxxxx pouze xx xxxxxxx xxxxxx x x) xxxxxxxx se Sportovec stane Sportovcem xxxxxxxxxxx xxxxxx&xxxx;xxxx xx xxxx xxxxxxxx&xxxx;Xxxxxxxxxxx xxxx, xxxxxx xxxx&xxxx;XX&xxxx;xxx xxxx xxxxx platná, xxxxx xxxxxx xxxxxx xxxxxxxxxx Xxxxxxxxxxx federací xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxx xxxx&xxxx;x xxxxxxx x xxxxxxx 7.0. Xxx by Národní antidopingová xxxxxxxxxx&xxxx;xxxx xxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxx, xxx xxxxxxxxx xxxxx x xxxxxxx&xxxx;XX&xxxx;Xxxxxxxxxxx xxxxxxxx nebo Organizátora xxxxxxxx Xxxx&xxxx;x xxxx xx xxx xxxx x xxxxxxxxx mu xxxxx procesu xxxxxxxx&xxxx;XX.
5.7&xxxx;Xxxxx Xxxxxxxxxxx xxxxxxxx nebo Organizátor xxxxxxxx Xxxx&xxxx;xxxx xxxxx xxxxxxxx (xxxxxxxxx tím, xx xxx xxxxxx xx dobře xxxxxxxxxx xxxxx na xxxxx xxxxxxxx stránkách x xxxxx&xxxx;XXXX), které xxxxx xxxxxxxxx (1) xxxxx&xxxx;Xxxxxxxxx, xxxx xxxxx xxx xxxxxx jurisdikci, je xxxx xxxxx o TV a xxx; (2) xxxxx xxxxxxxxxx o TV vydaná jinými Antidopingovými xxxxxxxxxxxx&xxxx;xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxxx xxxxxxx, x xxxxxxx x xxxxxxx 7.1 (a); x (3) xxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxx xxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxxxx&xxxx;xxxx xxxxx xxx xxxxxxxxx, xxx xxxx xxxxxx, x souladu x xxxxxxx 7.1 (x).
5.8&xxxx;Xxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxx&xxxx;XX Xxxxxxxxx&xxxx;x&xxxx;Xxxxxxxxx&xxxx;xx následně xxxxx&xxxx;Xxxxxxxxxx xxxxxxxxxxx úrovně nebo xx xxxxxxxx&xxxx;Xxxxxxxxxxx Xxxx,&xxxx;XX&xxxx;xxxxxx platná, xxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxx neuzná xxxx&xxxx;XX&xxxx;x xxxxxxx x článkem 7.0. Xxxxx Xxxxxxxxxxx xxxxxxxx udělí TV Sportovci x&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxx na Mezinárodní Xxxx&xxxx;xxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx Xxxx, xxxxxx&xxxx;XX&xxxx;xxxxxx, xxxxx a xxxxx xxxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxxxxx xxxx&xxxx;XX&xxxx;x xxxxxxx x xxxxxxx 7.0. Z xxxx xxxxx, xx xxxxx xxxxxxxxx Mezinárodní xxxxxxxx nebo xxxxxxxxx&xxxx;Xxxxxxxxxxx xxxxxxxxxx Akcí (podle xxxxxxx) xxxxxxx uznat tuto TV, xxxxx (xxxx xx xxx dotčeno právo Sportovce na xxxxxxxxxxx a xxxxxxxx) xxxx&xxxx;XX&xxxx;xxxxx xxx xxxxxxx xxxx xxxxxx u xxxx Mezinárodní federace xx&xxxx;Xxxxxxxxxxxx xxxxxxxxxx Xxxx&xxxx;xxx&xxxx;xxxxxxx,&xxxx;Xxxxxxx,&xxxx;Xxxxxx&xxxx;xx&xxxx;Xxxxxx Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxxxxx x dané TV.
6.0 Postup při xxxxxxxx xxxxxxx x&xxxx;XX
6.1&xxxx;Xxxxxxxxx, xxxxx xxxxxxxxx&xxxx;XX, by x xx měl xxxxx xx nejdříve. Xxx látky zakázané xxxxx&xxxx;Xxx Xxxxxxx&xxxx;xx xxx&xxxx;Xxxxxxxxx&xxxx;xxxxx x&xxxx;XX&xxxx;xxxxxxx xxxxxx (30) xxx xxxx xxxx&xxxx;Xxxxxxx, xxxxx xx nejedná x naléhavou xx xxxxxxxxxx xxxxxxx.
6.2&xxxx;Xxxxxxxxx&xxxx;xx měl xxxxx x xxx&xxxx;Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, Mezinárodní xxxxxxxx x/xxxx u Organizátora xxxxxxxxxx Xxxx&xxxx;(xxx xxxx, xxxx xxxxxxx xx xxxxxxxxx) xxxxxx xxxx xxxxxx příslušný formulář xxxxxxx x&xxxx;XX.&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xx xxxx xxxxxxxx formulář xxxxxxx xxxx xxxxxx, xxxxx chtějí, aby Sportovci používali, x xxxxxxxxxxx jej xx xxxxx xxxxxxxx xxxxxxx. Xxxxx se xxxxxxx formulář xxxxxxx, xxxx xxx xxxxxxx xx xxxxx "Xxxxxxxxx xxxxxxx x&xxxx;XX" dostupném xx webových xxxxxxxxx&xxxx;XXXX. Xxxxx vzor může xxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx xxx, xxx xxxxxxxxx další xxxxxxxxx na xxxxxxxxx, xxx xxxxx části xx xxxxxxx nesmí xxx xxxxxxxxx.
[Xxxxxxxx x xxxxxx 6.2: V xxxxxxxx xxxxxxxxx nemusí Xxxxxxxxx xxxxx, u xxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx by měl xxxxxxx o XX. Xx takových xxxxxxxxx xx xx xxx Xxxxxxxxx poradit s Xxxxxxx antidopingovou organizací x xxxx xxxxxxxxx xxxxxxxxxx, xx xxxxxx xxxxxxx (xxxx xx xxxxx xx xxxxxx xxxx xxxxxxxxx xxxxxxx), xxx xxxxxxx, xxx xxxxx xx oblasti xxxxxxxxxx pro XX xxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx podle xxxxxx xxxxxxxx.
Xxxxx tato Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxx žádost o XX, xxxxxxx Xxxxxxxxx xxxxxxx do xxxx xxxxxxxxxx, xxx by xx Xxxxxxxxx xxxxxxxx x xxxxxxxxxxxxxxx xxxxxxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx xxxx, xx xxxxx xx xxxxxxxx (xxxxx xx xxxx).
Xxxxx Sportovec xxxxx xxxxxxx do xxxxxxxxxx xxx TV xxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx, xxx by xx xxxxxxxx x xxxxxxxxxxxxxxx pravidly Národní xxxxxxxxxxxxx organizace xxxx xxxxx xxxxxxxxx (xxxxx xx xxxx xx xxxxx, xxx xxxxxxx xxxx xxxxx).
Xxxxxxxxx se xxxxx xxxxxxx xx xxxxxxxxxx x xxxx xxxxxxxxx Xxxxxxxxx antidopingových xxxxxxxxxx se xxxxxxx x xxxxx x xxxxxxx, xxx má xxxx Xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx pravomoc rozhodovat x XX. X xxxxxxx, xx xxxxx x xxxx xxxxxxxxx Xxxxxxxxx antidopingových xxxxxxxxxx xxxxxxxx xxxxxxxxxx x XX nemá, pokud xxxxx x Xxxxxxxxxxx xxxxxxxxxxxx nálezu, Xxxxxxxxx xx xxx xxx xxxxxxx xxxxxxx xxxxxxx x TV se xxxxxxx xxxxxxxxx x Xxxxxxxxxxxxx xxxxxxxxxx, která xx oprávnění x Xxxxxxxxx x výsledky. Xxx xxxx souhrnné xxxxxxxx diagramy x xxxxx "Xxx xxxxxxxα" x xxxxxxxx sekci xxxxxxxx xxxxxxx XXXX.]
6.3&xxxx;Xxxxxxxxx&xxxx;xxxxx xxxxxxx více xxx xxxxx (1)&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;x&xxxx;XX&xxxx;xx Xxxxxxx stejné Zakázané xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxx stejné xxxxxxxxx xxxxxx.&xxxx;Xxxxxxxxx&xxxx;xxxxx mít xxxxxxxx xxxx než jednu (1)&xxxx;XX&xxxx;xxx&xxxx;Xxxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx metody pro xxxxxx zdravotní potíže (x xxxxxxxx xxxxxx xxxx&xxxx;XX&xxxx;xxxxxxx xxxxxxxxx&xxxx;XX, xxxxx xx xxxx xxx xxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx).
6.4&xxxx;Xxxxxxxxx&xxxx;xx xxx xxxxx xxxxxx x&xxxx;XX&xxxx;x xxxxxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxxxxxxxxxx xxxxxxx&xxxx;XXXXX&xxxx;x/xxxx jiným xxxxxxxx xxxxxxx xxxxx&xxxx;Xxxxxxxxxxxxxx organizací. X xxxxxxx xx xxxxx xxxxxxxx úplnou xxxxxxxx, xxxxxx xxxxxxxxxxx xx původního xxxxxxxxxxxxxxxxx xxxxxx (lékařů) (xx-xx xx xxxxx) a xxxxxxxx xxxxx xxxxxxxxxxxx xxxxxxxxx, xxxxxxxxxxxxx xxxxxxxxx x snímků xxxxxxxxxxxxx xx xxxxxxx. Žádost xxxx xxx xx xxxxxxx xxxxx podepsána xxxxxxx.
[Xxxxxxxx k článku 6.4: Xxxxxxxxx xxxxxxxxxx x souvislosti x xxxxxxxxx x xxxxxx xx xxxx být x xxxxxxx x xxxxxxxxxxx xxxxxxxxx XXXX xxxxxxxxxx xx xxxxxxxx xxxxxxxxx XXXX.]
6.5&xxxx;Xxxxxxxxx&xxxx;xx si xxx ponechat xxxxxxxxx xxxxx xxxxxxx x&xxxx;XX&xxxx;x xxxxx xxxxx xxxxxxxxx x xxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx.
6.6&xxxx;Xxxxxx x&xxxx;XX&xxxx;xxxx xxxxxxxxx&xxxx;XXX&xxxx;xxxxx v xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx xxxxxxx, ke xxxxx xxxx xxx xxxxxxxxx xxxxxxx xxxxxxxxxx dokumenty. Xxxxxxxxxxx xxxxxx xxxx xxxxxxx&xxxx;Xxxxxxxxx, aby xx xxxxxxx x xxxxx xxxxx.
6.7&xxxx;XXX&xxxx;xxxx xxxxxxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxx xxxxxx jakékoli xxxxx xxxxxxxxx, vyšetření xxxx xxxxxx xx xxxxx xxxxx, xxxxx xx xxxx xxxx xxxxxxxx pro xxxxxxxxx xxxxxxx&xxxx;Xxxxxxxxx; a/nebo si xxxx xxxxxxx xxxxx xxxxxxxx či xxxxxxx xxxxxxxxx, považuje-li to xx vhodné.
6.8 Jakékoli náklady xxxxxxx x xxxxxxx xxxxxxx x&xxxx;XX&xxxx;x jejím xxxxxxxxxxx xxx požadavků KTV jsou xxxxxxx&xxxx;Xxxxxxxxxx.
6.9&xxxx;XXX&xxxx;xxxxxxxx, zda xxxxx, xxxx xxxxxxx&xxxx;XX, xx xxxxx xxxxxxxx x xxxxxxx (tj. xxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxx) xxxxx xx více xxx 21 dnů xx xxxxxxxx xxxxxxxxx xxxxxxx. X xxxxxxx, xx žádost x&xxxx;XX&xxxx;xx xxxxxx x xxxxxxxxxx xxxx xxxx&xxxx;Xxxx,&xxxx;XXX&xxxx;xxxxxx maximální xxxxx xxx dokončení xxxxxxxxxx žádosti o TV před xxxxxxxx&xxxx;Xxxx.
6.10&xxxx;Xxxxxxxxxx&xxxx;XXX&xxxx;xxxx být Sportovci sděleno xxxxxxx x xxxx xxx x xxxxxxxxx&xxxx;XXXX&xxxx;x xxxxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;xxxxxxxxxxxxxxx systému ADAMS v xxxxxxx x xxxxxxx 5.5.
6.11&xxxx;Xxxxx&xxxx;XX&xxxx;xxxx xxx určenou xxxx xxxxxx xxx xxxxxxxxxx&xxxx;XXX, xxxxxxxx&xxxx;XX&xxxx;xxxxx automaticky uplynutím xxxx doby. Xxxxx xxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxxx i nadále Používat Xxxxxxxxx xxxxx&xxxx;xxxx&xxxx;Xxxxxxxxx xxxxxx&xxxx;xx xxxxxxxx xxxxxxxxx&xxxx;XX, musí xx podat žádost x novou TV před uplynutím xxxx platnosti TV tak, aby xxxx xxxxx xxxxxxxxxx x xxxx žádosti x xxxxxxxxxx časové xxxxx xxxx xxxxxxxxx xxxxxxxxx&xxxx;XX.
[Xxxxxxxx x xxxxxx 6.11: Xxxx platnosti xx xxxx xxx xxxxxxxxx dle dokumentů XXXX "Lékařské informace xxx rozhodování x XX".]
6.12&xxxx;XX&xxxx;xxxx xxxxxxx ještě xxxx xxxxxxxxx xxxx xxxxxxxxx x xxxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx splňovat požadavky xxxx podmínky xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxx&xxxx;XX. Xxxxxxx udělení xx xxxxxxxxx&xxxx;XX&xxxx;xxxx xxx xxxxxxx xx xxxxxxx xxxxxxxxxxx&xxxx;XXXX&xxxx;xxxx xxxxxxxx.
6.13&xxxx;Xxxxx xx krátce xx xxxxxxxx xxxx xxxxxxxxx&xxxx;XX&xxxx;xxx xxxxx&xxxx;Xxxxxxxxx látku či xxxx, co xxxx&xxxx;XX&xxxx;xxxxxxx xx obnovena, xxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx xxxxx,&xxxx;Xxxxxxxxxxxxx organizace, xxxxx první xxxxxxxxxxx&xxxx;Xxxxxxxxx xxxxxxxxxxx nález v xxxxxxx x článkem 5.1.1.1&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxx&xxxx;Xxxxxxxxx x výsledky, xxxxxxxx, zda xxxxx xxxxxxxx&xxxx;Xxxxxxx Xxxxxxxx xxxxx&xxxx;xxxx xxxxxxxxx doby platnosti, xxxxxxxx xx změnou TV. Xxxxx ano, není xxxxxx&xxxx;Xxxxxxx&xxxx;(x xxx xxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxx xxxxx&xxxx;xx&xxxx;Xxxxxx Xxxxxxxxx) xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx.
6.14&xxxx;X xxxxxxx, xx poté, xx xx xxxxxxx&xxxx;XX,&xxxx;Xxxxxxxxx&xxxx;xxxxxxxx xxxxxxx jiné dávkování, xxxxxxxxx, xxxxxx xxxxx xx xxxx xxxxxx&xxxx;Xxxxxxxx Xxxxxxxx xxxxx&xxxx;xx&xxxx;Xxxxxxxx xxxxxx, xxx xxxxx xx xxxxxxx x&xxxx;XX, xxxx xxxxxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxxxxxx organizaci, xxxxx xxxxxxxx, xxx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxxxx x xxxxx&xxxx;XX. Xxxxx přítomnost, Použití, Držení či Podávání jinak Zakázané xxxxx&xxxx;xxxx&xxxx;Xxxxxxxx xxxxxx&xxxx;xxxx v xxxxxxx x xxxxxxxxxx, za xxxxxxx xxxx&xxxx;XX&xxxx;xxxxxxx, xxxxxxxxxx, xx&xxxx;Xxxxxxxxx&xxxx;xx&xxxx;XX, xxxxxxxxx konstatování, xx byla porušena xxxxxxxxxxxxx pravidla.
[Poznámka x xxxxxx 6.14: Xxxxxx xx, xx u xxxxxxxx xxxxxxxxxxx xxxxxx xxxx dávkování kolísat, xxxxxxx x raných xxxxxx zavádění xxxxxxxxx xxxxxx nebo x xxxxxx, jako je xxxxxxxx xxx závislosti xx inzulínu. Xxxx xxxxxxxxxxx výkyvy xx xxxx xxx xxxxxxxxxx x XX. X xxxxxxx xxxxx, xxxxx xxxx x TV xxxxxxxx, xxxx Sportovec xxxxxxxxxxx příslušnou Xxxxxxxxxxxxxx xxxxxxxxxx, xxx xxxxxxx, xxx xx xxxxxxxxxx xxxx XX.]
7.0&xxxx;Xxxxxx xxx xxxxxxxx&xxxx;XX
7.1&xxxx;Xxxxxx 4.4&xxxx;Xxxxxx&xxxx;xxxxxxxx, xxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx&xxxx;XX&xxxx;xxxxxxx jinými Antidopingovými xxxxxxxxxxxx, xxxxx xxxxxxx podmínky xxxxxx 4.2. Xxxxx xxxx&xxxx;Xxxxxxxxx, na nějž xx vztahují xxxxxxxxx&xxxx;XX&xxxx;xxxxxx Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxxx xxxxxxxx Akce, xxx&xxxx;XX&xxxx;xx, xxxxxx xxxxxxx xxxxxx x novou TV u této Xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxxxxxx významné Akce. Xxxxxxx xxxx:
x)&xxxx;Xxxxxxxxxxx xxxxxxxx xxxx&xxxx;Xxxxxxxxxxx xxxxxxxx Xxxx&xxxx;xxxxx xxxxxxxxx xxxxxxxx, xx xxxxxxxxxxx xxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxx x souladu x xxxxxxx 4.4&xxxx;Xxxxxx&xxxx;(xxxx xxxxxx kategorie xxxxxxxx xxxxxxxxxx, xxxx. rozhodnutí xxxxxxx xxxxxxxx&xxxx;Xxxxxxxxxxxxxxx xxxxxxxxxxxx&xxxx;xxxx xxxxxxxxxx xxxxxxxxxx xx xx konkrétním Xxxxxxxxx xxxxxx), za předpokladu, xx xxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxx xxxxxxxx x xxxxxxx x xxxxxxx 5.5. Xxxxx&xxxx;XX Xxxxxxxxx&xxxx;xxxxx xx xxxxxxxxx&xxxx;XX, xxxxx xxxx automaticky xxxxxxxx xxxxx xxxxxxxx v xxxx, xxx xx&xxxx;XX&xxxx;xxxxxxxxx, xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxx xxxxxxxx xxxxx xxxxx xxxxx. Jakmile xxxx&xxxx;XX&xxxx;xxxxxxxxxxx xxxxxx, xxxxx xxx xxxxxxxxx další xxxxxxxx ze strany Antidopingové xxxxxxxxxx.
[Xxxxxxxx x xxxxxx 7.1 (x): Xxxxxxxxxxx xxxxxxxx rozhodnutí o XX xxxx xxxxxxxxxxx xxxxxx xxx Xxxxxxxxx. Xxxxxxxxxxx xxxxxxxx a Xxxxxxxxxxxx xxxxxxxxxx xxxx xx však xxxx xxxxxxx xxxxxxx xxxxxxxxxxxxx xxxxxxxxxx x/xxxx xxxxx, xxx které xxxxx XX xxxxxxxxxxx xxxxxxx. Xxxxx Xxxxxxxxxxx xxxxxxxx xxxx Xxxxxxxxxxxx xxxxxxxxxx Xxxx chtějí xxxxxxxxxxx xxxxx xxxxxxxxxx x XX, xxxx xx xx xxxxx xxxxxxxx xxxxxxxxx xxxxxxxxx a xxxxxxxxxxxx Xxxxxx Xxxxxxxxxxxxxxx xxxxxxxxxx, jejichž xxxxxxxxxx x TV xxxxx xxxxxxxxxxx uznávat, a/nebo Xxxxxx těch Xxxxxxxxxx xxxxx, pro xxxxx xxxxx xxxxxxxxxx x XX xxxxxxxxxxx uznávat.]
b) V xxxxxxx, že xxxxxx xxxxxxxxxxx xxxxxx neexistuje, Sportovec podá xxxxxx o xxxxxx xxxxxxx&xxxx;XX&xxxx;xxxxxxxxx Xxxxxxxxxxx federaci xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxx Xxxx, x xx xxxxxxxxxxxxxxx&xxxx;XXXXX, xxxx xxxxx způsobem xxxxxxxxxxxxxx xxxxx Mezinárodní xxxxxxxx xx&xxxx;Xxxxxxxxxxxxx xxxxxxxx Xxxx.
[Xxxxxxxx x článku 7.1 (x): Uznání xx xxxxxxxx výhradně xx splnění podmínek xxxxxx 4.2. Xxxxx xxxxxxx doba xxxxxxxxx XX xxxx důvodem x zamítnutí xxxxxx (xxxxx xx xxxxxx xxxxxxx xxxxxxxx článku 4.2). Xxxx xxxxxxxxx XX xx xx xxxxxxxx xxxx xxxxx xxxxxxxxxx WADA s xxxxxx "Xxxxxxxx xxxxxxxxx xxx xxxxxxxxxxx x XX".]
7.2&xxxx;Xxxxxxx žádosti x xxxxxx&xxxx;XX&xxxx;xxxxx vráceny Sportovci k xxxxxxxx x xxxxxxxxxx xxxxxx. Xxxxx xxxx xxxx&xxxx;XXX&xxxx;xxxxxxxxx xx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxx xxxxxx xxxxxxxxx xxxxx informaci, xxxxxxxxx nebo xxxxxx xx xxxxx xxxxx, xxx xxxxxxxx za xxxxxxxx xxx posouzení xxxxxxx Xxxxxxxxx x xxxxxx&xxxx;XX; x/xxxx xx xxxx xxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxx, xxxxxxxx-xx xx xx vhodné.
7.3 Za xxxxxxx xxxxxxx, které Sportovci vzniknou xxx podání xxxxxxx x&xxxx;XX&xxxx;x xxxxx xxxxxxxxxx xxxxx xxxxxxxxx&xxxx;XXX, odpovídá Sportovec.
7.4 KTV rozhodne, xxx uzná, nebo xxxxxx&xxxx;XX, xx xxxxx xxxxxxxx, x obvykle (xx. xxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxx) do xxxxxxx jedna (21) xxx od obdržení xxxxxxxxx xxxxxxx x xxxxxx. Xxxxx xx xxxxxx podána x xxxxxxxxx xxxx xxxx xxxxxxx&xxxx;Xxxx,&xxxx;XXX&xxxx;xxxx xxxxxxxx maximální xxxxx, xxx xxxxxx xxx xxxxxxxxxx xxxx xxxxxxxxx&xxxx;Xxxx.
7.5&xxxx;Xxxxxxxxxx XXX bude xxxxxxx xxxxxxxx Sportovci x xxxx k xxxxxxxxx&xxxx;XXXX&xxxx;x dalším Antidopingovým organizacím prostřednictvím ADAMS. Xxxxxxxxxx xxxxxxx&xxxx;XX&xxxx;xxxx xxxxxxxxx xxxxxxxxxx důvodů xxx xxxxxxxx.
7.6&xxxx;Xxxxx xx Mezinárodní xxxxxxxx xxxxxxxx testovat Sportovce, xxxxx xxxx&xxxx;Xxxxxxxxxx xxxxxxxxxxx xxxxxx, musí xxxxx&xxxx;XX&xxxx;xxxxxxxx&xxxx;Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxx&xxxx;Xxxxxxxxx, xxxxx xxxx vyžadováno, aby xx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx o xxxxxx&xxxx;XX&xxxx;x xxxxxxx x články 5.8 a 7.0, xx. xxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxx xx&xxxx;Xxxxxxxxxxx Xxxx.
8.0&xxxx;Xxxxxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxxx&xxxx;XXXX
8.1&xxxx;Xxxxxx 4.4.6 Kodexu stanovuje, xx&xxxx;XXXX&xxxx;xxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx Mezinárodních xxxxxxxx x&xxxx;XX&xxxx;x xx xxxx přezkoumávat xxxxxxxx xxxxx rozhodnutí x&xxxx;XX, xxx xxxxxx v xxxxxx xxxxxxx soulad x xxxxxxxxxx xxxxxx 4.1 x 4.2. X xxxxxxxxxxx x xxxxxxxxxx xxxxxx 4.2&xxxx;XXXX&xxxx;xxxxx&xxxx;XXX&xxxx;XXXX. xxxxx xxxxxxx xxxxxxxxx xxxxxx 5.3 k xxxxxxxxx xxxxxx xxxxxxxx. X souvislosti x xxxxxxxxxx článku 4.1 xx xxxx přezkoumávat WADA (která xx xxxx dle xxxxx xxxxxxx xxxxxxxxxxx xx členem KTV WADA).
8.2 Každá xxxxxx x přezkoumání musí xxx podána xxxxxxxxxx&xxxx;XXXX&xxxx;xxxxxxxx xxxxxx x xxxx xxx xxxxxxxx doklad x xxxxxxxxx příslušného xxxxxxxx za xxxxxx xxxxxxxxxxx&xxxx;XXXX, a xxxx xxxx xxxxx xxxxx xxxxx xxxxxxxxxxxxxxx v xxxxxx 6.4 (xxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxx&xxxx;XX&xxxx;xxxxxxx xxxxx, xxxxx&xxxx;Xxxxxxxxx&xxxx;xxxxxxxxx x xxxxxxxxxxx x xxxxxxx xxxxxxx o TV). Xxxx být xxxxxxxxx xxxxx xxxxxxx xxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxx, jejíž xxxxxxxxxx xx předmětem xxxxxxxxxxx, x pro Sportovce (pokud xxxxxx x dané xxxxxxxxxxx).
8.3&xxxx;X xxxxxxx žádosti x xxxxxxxxxxx xxxxxxxxxx o TV, xxxxx&xxxx;XXXX&xxxx;xxxx povinna xxxxxxxxxxxx,&xxxx;XXXX&xxxx;xx xxxxxxxx po obdržení xxxxxxx informuje Xxxxxxxxx, xxx xxxx xxxxxxxxxx x&xxxx;XX&xxxx;xxxxxxxxx, xx nikoli. Xxxxxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;xxxxxxxxxxxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxxxx x xxxxx xx xxxxx xxxx xxxxxxx. Nicméně xxxxx xxxxxxxxxx x&xxxx;XX&xxxx;xx xxxxx lze odvolat, xxx xx stanoveno x xxxxxx 4.4.7&xxxx;Xxxxxx.
8.4&xxxx;X xxxxxxx žádosti o xxxxxxxxxxx xxxxxxxxxx o TV, xxxxxxxxx Xxxxxxxxxxx xxxxxxxx, xxxxx je WADA povinna xxxxxxxxxxxx, xxxx&xxxx;XXXX&xxxx;xxxxxxx xxxxxx xxxxxxxxxx xxxx Xxxxxxxxxxx xxxxxxxx (x) x xxxxxx xxxxxxxxx (xxxxxxxxx, xxxxx xxxxxx x xxxxxxxxxx xxxxx xxxxxxxxx důvody); x/xxxx xx (x) x xxxxxxxxxx xxxxxxx Xxxxxxxxxxx federací (xxxxxxxxx, xxxxx&xxxx;XX&xxxx;xxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxxx xxxxxxxxx xxxxxx xxxx jiným xxxxxxxxxx xxxxxx, xxxxxxxxxxx x xxxxxxxxx xxxxxxx xxxxxxxx xxxxxx 4.2).
[Xxxxxxxx x článku 8.4: Xxxxx Xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxx XX xxxxxxxx Xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxxx xxxxxxxxx testům xxxx jiným xxxxxxxxxx xxxxxx, xxxxxxxxxxx x xxxxxxxxx splnění podmínek xxxxxx 4.2, záležitost xx xxxxxx být xxxxxxxxxx WADA. Místo xxxx xx xxx xxx xxxx xxxxxxx x xxxxx odeslán Xxxxxxxxxxx xxxxxxxx.]
8.5&xxxx;X případě, xx xx xxxxxx x přezkoumání xxxxxxxxxx&xxxx;XXX&xxxx;XXXX.&xxxx;XXX&xxxx;XXXX&xxxx;xx xxxx xxxxxxx další xxxxxxxxx xx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;x/xxxx xx&xxxx;Xxxxxxxxx, xxxxxx xxxxxxx xxxxxx xxxxxxxxx x xxxxxx 6.7, x/xxxx xx může xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxx, xxxxxxxx-xx xx xx xxxxxx.
8.6&xxxx;XXXX&xxxx;xxxxx xxxxxxxx xxxxxxx&xxxx;XX, xxxxx nesplňuje xxxxxxxx xxxxxx 4.1 x 4.2 (xxx xxxxxxx). X xxxxxxx, že xxxxxxx&xxxx;XX&xxxx;xxxx&xxxx;XX&xxxx;x budoucí xxxxxxxxx (xx xxxxxx xx&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx), nabude xxxxxx xxxxxxx xxxxxxxxx xxxx určeným WADA (což xxxxxx xxxxx než xxxxx xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;xx xxxxxx&xxxx;XXXX). Xxxxxxx xxxxxxx xxxxxx x xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;xxxx xxxxx oznámením xxxxxxx&xxxx;Xxxxxxxxx. X případě, xx xxxxxxx&xxxx;XX&xxxx;xxxx&xxxx;XX&xxxx;xx xxxxxxx xxxxxxxxx, xx xxxx xxxxxxx xxxx xxxxxxx xxxxxxxx.
8.7&xxxx;XXXX&xxxx;xxxxx xxxxxxxx xxxxxxxxx&xxxx;XX&xxxx;x xxxxxxx, xxx xxxxxx x&xxxx;XX&xxxx;xxxxxxx xxxxxxxx xxxxxx 4.1 a 4.2 (xxx situace), xx. xxxxx&xxxx;XX.
8.8&xxxx;Xxxxx&xxxx;XXXX&xxxx;xxxxxxxxxxx rozhodnutí Xxxxxxxxxxx xxxxxxxx, xxxxx xx xxxx xxxxxxx x xxxxxxx x xxxxxxx 4.4.3&xxxx;Xxxxxx&xxxx;(xx. povinné xxxxxxxxxxx), xxxx xxxxxxxxx, xxx xxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace, xxxxx "xxxxxxxx" xxx xxxxxxxxxxx (xx. Antidopingová xxxxxxxxxx, xxxxx stanovisko není xxxxxxxxx), (x) proplatila xxxxxxxx xx xxxxxx xxxxxxx straně, xxxxx xxxxxxxxxx xxxxxxxxxx&xxxx;XXXX&xxxx;(xx-xx xx xxxxxxxxxx); x/xxxx (x) xxx xxxxxxxxx xxxxxxx xxxxxxx&xxxx;XXXX&xxxx;x souvislosti x xxxxx xxxxxxxxxxxx do xxxx, xxxxx xxx xxxx xxxxxxx xxxxxxxxx xx xxxxxx xxxxxxx.
8.9&xxxx;X xxxxxxx, xx&xxxx;XXXX&xxxx;xxxxx xxxxxxxxxx x&xxxx;XX, xxxxx se WADA rozhodla xxxxx svého xxxxxxx xxxxxxxxxx,&xxxx;XXXX&xxxx;xxxx xxxxxxxxx, xxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx, která xxxxxxx xxxxxxxxxx, xxxxxxxxx náklady xxxxxxx&xxxx;XXXX&xxxx;x souvislosti x xxxxx přezkoumáním.
8.10 Je-li xx xxxxxxxxxx,&xxxx;XXXX&xxxx;xxxxx odůvodněné rozhodnutí KTV WADA neprodleně Sportovci a xxxx&xxxx;Xxxxxxx antidopingové organizaci a Xxxxxxxxxxx xxxxxxxx (x, xx-xx xx xxxxxxxxxx,&xxxx;Xxxxxxxxxxxxxx xxxxxxxx Xxxx).
9.0&xxxx;Xxxxxxxxx xxxxxxxxx
9.1&xxxx;Xxxxxxxxxx Xxxxxxxx&xxxx;xxxxx xxxxx procesu TV Xxxxxxxxxxxxxxx xxxxxxxxxxxx&xxxx;xxxx xxx x xxxxxxx s Mezinárodním xxxxxxxxxx&xxxx;xx xxxxxxx xxxxxxxx x xxxxxxxx xxxxx.&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;xxxxxxx, xxx xxxx xxxxxx xxxxxxxxx nebo xxxxxx xxxxxx xxx xxxxxx&xxxx;Xxxxxxxxxx&xxxx;x xxxxxxx s Mezinárodním xxxxxxxxxx&xxxx;xx ochranu xxxxxxxx x osobních xxxxx x platnými xxxxxx.
9.2&xxxx;Xxxxxxxxxxxxx xxxxxxxxxx&xxxx;x souladu s xxxxxxx 7.1 Mezinárodního standardu na xxxxxxx soukromí x xxxxxxxx údajů xxxxxxx xxxxx&xxxx;Xxxxxxxxxx&xxxx;xxxxxxxxxxx xxxxxxxxx x xxxxxxxxxxx x žádostí Sportovce o xxxxxxx xxxx xxxxxx&xxxx;XX:
x)&xxxx;Xxxxxxx xxxxxxxxx xxxxxxxx se xxxxxxx xxxxx předány xxxxxx xxxxx&xxxx;XXX&xxxx;x xxxxxxxxxx xxxxx xxxxxx&xxxx;Xxxxxxxxxxxxx xxxxxxxxx&xxxx;xxxxxxxxxxxx xxxx x podle xxxxxxx xxxxxx nezávislým xxxxxxxxx xxxx xxxxxxxx xxxxxxxxxx x všem xxxxxxxxx xxxxxxxxxxx (xxxxxx xxxxxxxxxx&xxxx;XXXX) xxxxxxxxx do xxxxxx, xxxxxxxxxxxxx nebo xxxxxxxx xxxxxxx o TV;
b) Sportovec musí xxxxxxx xxxxx xxxxxx (xxx xxxxxx), xxx xx xxxxxxxx poskytl xxxxxxxxx&xxxx;XXX&xxxx;xxxxxxxx zdravotní xxxxxxxxx, xxxxx xxxxxxxx příslušná KTV za xxxxxxxx pro xxxxxxxxx x rozhodnutí o xxxxxxx&xxxx;Xxxxxxxxx; x
x)&xxxx;Xxxxxxxxxx x xxxxxxx xxxx xxxxxxxxxxxx xxxx&xxxx;Xxxxxxxxxxxxxx xxxxxxxxxxx&xxxx;x oprávněním xxxxxxxx&xxxx;Xxxxxxxxx&xxxx;x/xxxx xxxxxx pro Nakládání x xxxxxxxx&xxxx;x xxxxxxxxx xxxxxxxxxx se k xxxxxx&xxxx;Xxxxxxxxx.
[Xxxxxxxx x článku 9.2: X případech, xxx xx Xxxxxxxxxxxxx xxxxxxxxxx opírají x xxxxxxx Xxxxxxxxx se Xxxxxxxxxxx Xxxxxxxx xxxxx x souvislosti s xxxxxxxx TV, Xxxxxxxxx xxxxxxxx o udělení xxxx xxxxxx XX xxxxxxxx písemný a xxxxxxxx souhlas x xxxx xxxxxxxx.]
9.3&xxxx;Xxxxxx x&xxxx;XX&xxxx;xxxx xxxxxx x souladu x principy xxxxxx xxxxxxxx xxxxxxxxxxxx. Xxxxxxx xxxxx xxxxxxxxxxx&xxxx;XXX, xxxxxxxxx xxxxxxxxx x příslušní xxxxxxxxxx&xxxx;Xxxxxxxxxxxxx organizace budou při xxxxx xxxxx xxxxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxxx přísnou mlčenlivost x xxxxxxxx příslušné xxxxxxx o xxxxxxx xxxxxxxxx xxxxxxxxx. Budou xxxxxxxxxx mlčenlivost xxxxxxx x:
x)&xxxx;xxxxxxxxx xxxxxxxxxx informacích xxxxxxxxxxxx&xxxx;Xxxxxxxxxx&xxxx;x xxxxxxx (xxxxxx), xxxxx se péče x&xxxx;Xxxxxxxxx&xxxx;xxxx; x
x)&xxxx;xxxxxxxxx xxxxxxxxxxxxx xxxxxxx, včetně jména xxxxxx (xxxxxx) xxxxxxxxxx xx xxxx záležitosti.
9.4 Pokud xx&xxxx;Xxxxxxxxx&xxxx;xxxxx odvolat právo KTV na xxxxxxxxx xxxxxxxxxx zdravotních xxxxxxxxx xxxx xxxxxx, xxxxxx xxxx odvolání xxxxx xxxxxx xxxxxxxx xxxxxx; za podmínky, xx xxxx důsledek xxxxxx xxxxxxxx bude xxxxxx&xxxx;Xxxxxxxxx&xxxx;x&xxxx;XX&xxxx;xxxx o xxxxxx xxx existující TV považována xx xxxxxxxx, aniž xx xxxx xxxxxxx schválení/uznání.
9.5 Antidopingové xxxxxxxxxx&xxxx;xxxxx xxxxxxxx xxxxx xxxxxxxxx xxxxxxxxxx&xxxx;Xxxxxxxxxx&xxxx;x xxxxxxxxxxx x xxxxxxx x&xxxx;XX&xxxx;x xxxxxxxxxxx žádostí x x souvislosti x xxxxxxx xxxxxxxxxxxxx x xxxxxxxx xxx xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx.
XXXXXXX 1: XXXXXXXXX DIAGRAM XXX XXXXXX 4.4 XXXXXX
1.&xxxx;Xxxxxx xxx xxxxxxx x&xxxx;XX&xxxx;x xxxxxxx, že Sportovec není Sportovcem mezinárodní úrovně, xxxx potřebuje TV
2. Postup xxx xxxxxxx x&xxxx;XX&xxxx;x xxxxxxx, xxx xx&xxxx;Xxxxxxxxx&xxxx;Xxxxxxxxxx mezinárodní xxxxxx&xxxx;(x xxxxxxx tedy xxxxxxxxxx xx&xxxx;XX&xxxx;Xxxxxxxxxxx federace), xxxx potřebuje XX
3.&xxxx;Xxxxxxxxx&xxxx;xx xxxxxxx&xxxx;Xxxx, pro xxxxxx xx&xxxx;Xxxxxxxxxxx xxxxxxxx akce (OVA) xxxxxxx xxxxxxxxx
Xxxxxxxxx
Xxxxxx xxxxxxx č. 32/2023 Xx. x. x. xxxxx xxxxxxxxx xxxx 22.8.2023.
Xxxxxx xxxxxxx x. 32/2023 Xx. x. s. xxx xxxxxx právním xxxxxxxxx č. 19/2025 Sb. x účinností xx 28.1.2025.
Xxxxx jednotlivých xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační změna xxxxx xxxxxxxxx právního xxxxxxxx.
1) Mezinárodní xxxxxx xxxxx xxxxxxx xx xxxxxx, přijatá xxx 19. října 2005 x Xxxxxx, xxxx xxxxxxxxx x anglickém xxxxx a s xxxxxxxxx do xxxxxxx xxxxxx pod č. 58/2007 Sb. m. s.
Xxxx xxxxx překladu Xxxxxx xx českého xxxxxx xxxx xxxxxxxxx pod č. 46/2008 Sb. m. s.
2) Xxxxxxx X xxx xxx 2022 xxxxxx xxxxxxxxx xx Xxxxxx mezinárodních xxxxx, xxxxx xxx 22. xxxxxx 2023 xxxxxxx xxxxxxxxx xxx Českou xxxxxxxxx.
3) Xxxxxxx X xxx xxx 2018 xxxx xxxxxxxxx xxx č. 36/2019 Sb. m. s.
4) Xxxxxxx XX xxx xxx 2016 xxxx xxxxxxxxx xxx č. 26/2017 Sb. m. s.